Denison Reports CNSC Hearing Dates for Phoenix ISR Project

PR Newswire


TORONTO
, Feb. 27, 2025 /PRNewswire/ – Denison Mines Corp. (“Denison” or the “Company“) (TSX: DML) (NYSE American: DNN) is pleased to announce that the Canadian Nuclear Safety Commission (“CNSC“) Registrar has set the schedule for the CNSC public hearing (“Hearing“) for the Wheeler River Uranium Project (“Wheeler River“, or the “Project“). The Hearing is scheduled to be held in two parts (October 8, 2025, and December 8 to 12, 2025) and represents the final step in the federal approval process for the Project’s Environmental Assessment (“EA“) and Licence to Prepare and Construct a Uranium Mine and Mill (“Licence“). View PDF Version

Based on this schedule, if the CNSC makes a prompt decision to approve the Project following the completion of the Hearing, the Company expects to be able to commence site preparation and construction activities for the Phoenix In-Situ Recovery (“ISR“) project in early 2026.

The announcement of the Hearing schedule follows the successful completion of multiple key regulatory milestones in late 2024, including (i) completion of the technical review phase of the federal EA approval process in November, (ii) acceptance by the CNSC of the Company’s final Environmental Impact Statement (“EIS“) for the Project in December, and (iii) the CNSC’s determination of the sufficiency of Denison’s Licence application, also in November. These accomplishments indicate that the CSNC staff support the advancement of the Project and are transitioning their efforts to prepare an evidence-based summary report for the Commission members that will govern the Hearing and render their decision on the EA and Licence once the Hearing is complete. 

David Cates, President and CEO of Denison commented, “The scheduling of the Hearing and acceptance of the final federal EIS by the CNSC represent significant additional achievements for Denison in our efforts to obtain the regulatory approvals necessary to commence construction of the Phoenix ISR uranium mining operation. Importantly, obtaining clarity on the Hearing schedule significantly reduces uncertainty regarding the timeline for Federal project approvals and allows our operations team to finalize our construction planning efforts with greater precision. With the potential to commence construction in early 2026, we expect to be able to maintain our target of achieving first production from Phoenix by the first half of 2028.”

About Denison

Denison is a leading uranium mining, development, and exploration company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. Denison has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure rich eastern portion of the Athabasca Basin region of northern Saskatchewan. In mid-2023, the Phoenix feasibility study was completed for the Phoenix deposit as an ISR mining operation, and an update to the previously prepared 2018 Pre-Feasibility Study (‘PFS’) was completed for Wheeler River’s Gryphon deposit as a conventional underground mining operation. Based on the respective studies, both deposits have the potential to be competitive with the lowest cost uranium mining operations in the world. Permitting efforts for the planned Phoenix ISR operation commenced in 2019 and several notable milestones were achieved in 2024 with the submission of federal licensing documents and the acceptance of the final form of the project’s Environmental Impact Statement by the Province of Saskatchewan and the Canadian Nuclear Safety Commission.

Denison’s interests in Saskatchewan also include a 22.5% ownership interest in the McClean Lake Joint Venture (‘MLJV’), which includes unmined uranium deposits (planned for extraction via the MLJV’s SABRE mining method starting in 2025) and the McClean Lake uranium mill (currently utilizing a portion of its licensed capacity to process the ore from the Cigar Lake mine under a toll milling agreement), plus a 25.17% interest in the Midwest Joint Venture (‘MWJV’)’s Midwest Main and Midwest A deposits, and a 69.44% interest in the Tthe Heldeth Túé (‘THT’) and Huskie deposits on the Waterbury Lake Property (
‘Waterbury’
). The Midwest Main, Midwest A, THT and Huskie deposits are located within 20 kilometres of the McClean Lake mill. Taken together, Denison has direct ownership interests in properties covering ~384,000 hectares in the Athabasca Basin region.

Additionally, through its 50% ownership of JCU (Canada) Exploration Company, Limited (‘JCU’), Denison holds interests in various uranium project joint ventures in Canada, including the Millennium project (JCU, 30.099%), the Kiggavik project (JCU, 33.8118%) and Christie Lake (JCU, 34.4508%).

In 2024, Denison celebrated its 70th year in uranium mining, exploration, and development, which began in 1954 with Denison’s first acquisition of mining claims in the Elliot Lake region of northern Ontario.

Follow Denison on Twitter @DenisonMinesCo

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 

Certain information contained in this press release constitutes ‘forward-looking information’, within the meaning of the applicable United States and Canadian legislation concerning the business, operations and financial performance and condition of Denison. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as ‘plans’, ‘expects’, ‘budget’, ‘scheduled’, ‘estimates’, ‘forecasts’, ‘intends’, ‘anticipates’, or ‘believes’, or the negatives and/or variations of such words and phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will be taken’, ‘occur’, ‘be achieved’ or ‘has the potential to’.

In particular, this press release contains forward-looking information pertaining to the Company’s expectations with respect to the Hearing and the EA and Licensing process, development plans for Wheeler River and the proposed ISR operation for the Phoenix deposit; expectations regarding Denison’s joint venture ownership interests; and expectations regarding the objectives and continuity of its agreements with third parties. Statements relating to ‘mineral reserves’ or ‘mineral resources’ are deemed to be forward-looking information, as they involve the implied assessment, based on certain estimates and assumptions that the mineral reserves and mineral resources described can be profitably produced in the future.

Forward looking statements are based on the opinions and estimates of management as of the date such statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Denison to be materially different from those expressed or implied by such forward-looking statements. For example, the results of the Hearing may not be as anticipated. In addition, Denison may decide or otherwise be required to discontinue development work if it is unable to maintain or otherwise secure the necessary approvals or resources (such as testing facilities, capital funding, etc.). Denison believes that the expectations reflected in this forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be accurate and results may differ materially from those anticipated in this forward-looking information. For a discussion in respect of risks and other factors that could influence forward-looking events, please refer to the factors discussed in the Company’s Annual Information Form dated March 28, 2024 under the heading ‘Risk Factors’. These factors are not, and should not be, construed as being exhaustive.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking information contained in this press release is expressly qualified by this cautionary statement. Any forward-looking information and the assumptions made with respect thereto speaks only as of the date of this press release. Denison does not undertake any obligation to publicly update or revise any forward-looking information after the date of this press release to conform such information to actual results or to changes in Denison’s expectations except as otherwise required by applicable legislation.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/denison-reports-cnsc-hearing-dates-for-phoenix-isr-project-302387197.html

SOURCE Denison Mines Corp.

VIAVI, AT&T and Verizon Announce Collaboration to Accelerate Testing of Open RAN

PR Newswire


CHANDLER, Ariz.
, Feb. 27, 2025 /PRNewswire/ — VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced a strategic partnership between VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™) and the Acceleration of Compatibility and Commercialization for Open RAN Deployments (ACCoRD) project led by AT&T and Verizon. As co-grantees of the U.S. National Telecommunications and Information Administration (NTIA) Public Wireless Supply Chain Innovation Fund, VALOR and ACCoRD will collaborate on Open RAN testing initiatives to further the adoption of open and interoperable network components, strengthen global supply chain resiliency and lower barriers to entry for new Open RAN players.

VIAVI will initially supply ACCoRD labs at Iowa State University and Rutgers University with the NITRO® Wireless Open RAN Test Suite, supported by the VIAVI Automation Management and Orchestration System (VAMOS). In addition, VALOR’s full suite of O-RAN tests will be available to customers referred to the VALOR lab by ACCoRD. Equipment and services will also be provided to an additional lab at the University of Texas at Dallas in 2026 to support preparation for ACCoRD test service sustainability beyond the grant period.

“At AT&T, we are dedicated to driving technological innovation and enhancing network performance,” said Robert Soni, Vice President, RAN Technology, AT&T. “Collaborating with VIAVI and Verizon through the ACCoRD project allows us to advance our Open RAN initiatives, ultimately benefiting our stakeholders with improved network capabilities and greater flexibility.”

“Verizon has been driving the adoption of O-RAN for years by being a leading voice in developing and adopting O-RAN standards, paving the way for greater competition, innovation, and cost savings in the telecommunications industry,” said Steven Rice, Vice President, Network Planning, Verizon. “Through collaboration with VIAVI and AT&T in the ACCoRD labs, we expect to accelerate Open RAN networks with improved resilience and network performance that benefit operators and customers.”

“We are delighted to support ACCoRD with testbeds through our VALOR lab and the integration of our end-to-end Open RAN portfolio at the consortium’s laboratories,” said Oleg Khaykin, President and CEO, VIAVI Solutions. “With this collaboration, VALOR is well positioned to contribute to the evolution of Open RAN testing as it becomes more automated, cloud-based and efficient.”

VALOR is a hybrid Lab-as-a-Service and Test-as-a-Service lab based on VIAVI’s NITRO® Wireless test portfolio. It is designed to manage and support 5G and Open RAN deployments that would benefit from access to tools and expert staff with a minimal ramp-up time.

ACCoRD is a consortium led by AT&T and Verizon and includes NTT DOCOMO and Reliance Jio as founding members. ACCoRD will be centered at an Open RAN Testing, Evaluation and R&D Center in the Dallas area, with a satellite location in the Washington, D.C. area, all while taking advantage of the expertise of academic members of the consortium, including University of Texas at Dallas, Virginia Tech, Northeastern University, Iowa State University and Rutgers University.

About VIAVI

VIAVI (NASDAQ: VIAV) is a global provider of network test, monitoring and assurance solutions for telecommunications, cloud, enterprises, first responders, military, aerospace and railway. VIAVI is also a leader in light management technologies for 3D sensing, anti-counterfeiting, consumer electronics, industrial, automotive, government and aerospace applications. Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI Perspectives, LinkedIn and YouTube.

Media Inquiries:

Grand Bridges
Emma Jenkins
[email protected]
+1 415 800 4529

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viavi-att-and-verizon-announce-collaboration-to-accelerate-testing-of-open-ran-302387213.html

SOURCE VIAVI Solutions

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire

Topline pivotal data expected in 2025 for both TKI pre-treated ROS1-positive and TKI pre-treated ALK-positive NSCLC populations

First NDA submission planned for mid-year 2025 towards potential first approval in 2026 for zidesamtinib in TKI pre-treated ROS1-positive NSCLC population

Development strategies in place for TKI-naïve populations, including planned initiation of ALKAZAR Phase 3 randomized, controlled trial of neladalkib for front-line ALK-positive NSCLC in first half of 2025

Implemented global Expanded Access Programs for zidesamtinib and neladalkib, in line with goal of prioritizing patient access


CAMBRIDGE, Mass.
, Feb. 27, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today outlined pipeline and business progress, reiterated key anticipated milestones,  and reported fourth quarter and full year 2024 financial results.

“The efficient execution by the Nuvalent team to date reflects a shared sense of urgency driven by patient need for additional treatment options – a need that we believe has been clearly demonstrated by the robust enrollment momentum in our ARROS-1 and ALKOVE-1 trials,” said Darlene Noci, A.L.M., Chief Development Officer at Nuvalent. “We believe we are on track to report pivotal data for TKI pre-treated patients from both trials this year and to submit our first NDA by mid-year 2025.”

Ms. Noci continued, “In parallel to advancing initial registration paths for zidesamtinib and neladalkib for TKI pre-treated patients, we continue to work with regulators towards our goal of bringing new therapies to all patients with ROS1-positive or ALK-positive NSCLC. Development programs for TKI-naïve patients are underway for both our ROS1 and ALK programs. To ensure patient access to these therapies, we are also pleased to announce the recent launch of global Expanded Access Programs for patients who are eligible and have no other treatment options outside of a clinical trial.”

“As we transition towards becoming a fully integrated commercial-stage biopharmaceutical company, we reiterate our commitment to meeting the medical needs of patients by advancing our programs as quickly as possible,” said James Porter, Ph.D., Chief Executive Officer at Nuvalent. “This is an important time for Nuvalent and with a steady cadence of anticipated milestones across our pipeline this year, a strong balance sheet and a dedicated and proven team at the helm, we believe we are well-positioned to deliver on our near-, mid- and long-term goals.”

Recent Pipeline Progress and Anticipated Milestones

ROS1 Program

  • Nuvalent has implemented a global Expanded Access Program (EAP) for zidesamtinib for eligible patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have previously received at least one prior ROS1 tyrosine kinase inhibitor (TKI) and lack satisfactory therapeutic alternatives and are unable to access zidesamtinib through a clinical trial.
  • As of December 31, 2024, a total of 430 patients had been enrolled in the Phase 1 and Phase 2 portions of the ongoing ARROS-1 Phase 1/2 trial of zidesamtinib for patients with advanced ROS1-positive NSCLC and other solid tumors, which is designed with registrational intent for TKI pre-treated and TKI-naïve patients with advanced ROS1-positive NSCLC. The company expects to report pivotal data for TKI pre-treated patients with advanced ROS1-positive NSCLC in the first half of 2025 in support of an anticipated New Drug Application (NDA) submission by mid-year 2025, with an initial target indication of TKI pre-treated patients with advanced ROS1-positive NSCLC. The company plans to continue engagement with the U.S. Food and Drug Administration (FDA) on accelerated opportunities towards a potential line-agnostic indication supported by the ongoing TKI-naïve cohort in the Phase 2 portion of the ARROS-1 trial.

ALK Program

  • Nuvalent has implemented a global EAP for neladalkib for eligible patients with locally advanced or metastatic ALK-positive NSCLC who have previously received lorlatinib or a second-generation ALK TKI and lack satisfactory therapeutic alternatives and are unable to access neladalkib through a clinical trial.
  • As of December 31, 2024, a total of 596 patients had been enrolled in the Phase 1 and Phase 2 portions of the ongoing ALKOVE-1 Phase 1/2 trial of neladalkib for patients with advanced ALK-positive NSCLC and other solid tumors, which is designed with registrational intent for TKI pre-treated patients. The company expects to report pivotal data for TKI pre-treated patients with advanced ALK-positive NSCLC by year-end 2025.
  • Nuvalent plans to initiate the ALKAZAR Phase 3 trial, its front-line development strategy for the company’s ALK program, in the first half of 2025. The Phase 3 ALKAZAR trial will be a global, randomized, controlled trial designed to evaluate neladalkib versus the current standard of care for the treatment of patients with TKI-naïve ALK-positive NSCLC. Patients will be randomized 1:1 to receive neladalkib monotherapy or ALECENSA® (alectinib) monotherapy, reflecting input from collaborating physician-scientists and alignment with the FDA.

HER2 Program

  • Enrollment is ongoing in the HEROEX-1 Phase 1a/1b clinical trial evaluating the overall safety and tolerability of NVL-330 for pre-treated patients with HER2-altered NSCLC. Additional objectives include determination of the recommended Phase 2 dose, characterization of NVL-330’s pharmacokinetic profile, and preliminary evaluation of anti-tumor activity. The company expects to continue to progress the HEROEX-1 trial throughout 2025.

Business Updates

  • Appointed Grant Bogle to Board of Directors: As previously announced, Nuvalent appointed Grant Bogle to its board of directors in December 2024. Mr. Bogle brings nearly four decades of proven leadership in building and growing biotechnology companies to the Nuvalent board. Throughout his career, he has served in senior leadership roles at several specialty pharmaceutical and biotechnology companies and worked alongside oncologists as part of the leadership of U.S. Oncology, the largest network of community oncology practices in the United States. He has a proven track record of success in the field of oncology and has guided numerous products from early-stage development to commercialization. Most recently, Mr. Bogle was the Chief Executive Officer at Epizyme, Inc., and oversaw the 2022 acquisition of the company by Ipsen. Prior to that, Mr. Bogle was Senior Vice President and Chief Commercial Officer of TESARO, which was acquired by GlaxoSmithKline in 2018. Earlier, he served as Senior Vice President of Pharmaceutical and Biotech Solutions at McKesson Specialty Health (formerly U.S. Oncology).

Fourth Quarter and Full Year 2024 Financial Results

  • Cash Position: Cash, cash equivalents and marketable securities were $1.1 billion as of December 31, 2024. Nuvalent continues to believe that its existing cash, cash equivalents and marketable securities will be sufficient to fund its current operating plan into 2028.
  • R&D Expenses: Research and development (R&D) expenses were $69.4 million for the fourth quarter of 2024 and $217.8 million for the year ended December 31, 2024.
  • G&A Expenses: General and administrative (G&A) expenses were $16.9 million for the fourth quarter of 2024 and $62.6 million for the year ended December 31, 2024.
  • Net Loss: Net loss was $74.8 million for the fourth quarter of 2024 and $260.8 million for the year ended December 31, 2024.

About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, implied and express statements regarding Nuvalent’s strategy, business plans, and focus; Nuvalent’s estimated cash runway; the expected timing of data announcements, clinical trial initiations, FDA submissions and potential product approval; the clinical development programs for zidesamtinib, neladalkib and NVL-330; the timing of the ALKAZAR trial; the potential clinical effects of Nuvalent’s product development candidates; the design and enrollment of Nuvalent’s clinical trials, including for ARROS-1 and ALKOVE-1 their intended pivotal registration-directed design; the potential of Nuvalent’s pipeline programs, including zidesamtinib, neladalkib and NVL-330; the implications of data readouts and presentations; timing and content of potential discussions with FDA regarding potential accelerated approval pathways; Nuvalent’s potential buildout of a commercial infrastructure; Nuvalent’s research and development programs for the treatment of cancer; and risks and uncertainties associated with drug development. The words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “aim,” “goal,” “intend,” “believe,” “expect,” “estimate,” “seek,” “predict,” “future,” “project,” “potential,” “continue,” “target” or the negative of these terms and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. You should not place undue reliance on these statements or the scientific data presented.

Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation: risks that Nuvalent may not fully enroll its clinical trials or that enrollment will take longer than expected; unexpected concerns that may arise from additional data, analysis, or results obtained during preclinical studies and clinical trials; the risk that results of earlier clinical trials may not be predictive of the results of later-stage clinical trials; the risk that data from our clinical trials may not be sufficient to support registration and that Nuvalent may be required to conduct one or more additional studies or trials prior to seeking registration of our zidesamtinib or neladalkib product candidates; risks that Nuvalent may not achieve the goals and milestones set forth in its OnTarget 2026 operating plan; the occurrence of adverse safety events; risks that the FDA may not approve our potential products on the timelines we expect, or at all; risks of unexpected costs, delays, or other unexpected hurdles; risks that Nuvalent may not be able to nominate drug candidates from its discovery programs; the direct or indirect impact of public health emergencies or global geopolitical circumstances on the timing and anticipated timing and results of Nuvalent’s clinical trials, strategy, and future operations, including the ARROS-1, ALKOVE-1, ALKAZAR and HEROEX-1 trials; the timing and outcome of Nuvalent’s planned interactions with regulatory authorities; and risks related to obtaining, maintaining, and protecting Nuvalent’s intellectual property. These and other risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in Nuvalent’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, as well as any prior and subsequent filings with the Securities and Exchange Commission. In addition, any forward-looking statements represent Nuvalent’s views only as of today and should not be relied upon as representing its views as of any subsequent date. Nuvalent explicitly disclaims any obligation to update any forward-looking statements.

 


CONSOLIDATED STATEMENTS OF OPERATIONS


(In thousands, except share and per share amounts)


(Unaudited)


Three Months Ended December 31,


Year ended December 31,


2024


2023


2024


2023

Operating expenses

Research and development

$                 69,423

$                 35,585

$               217,774

$               113,243

General and administrative

16,876

10,852

62,594

36,249

Total operating expenses

86,299

46,437

280,368

149,492

Loss from operations

(86,299)

(46,437)

(280,368)

(149,492)

Other income (expense)

Change in fair value of related party revenue share liability

(1,340)

(17,940)

Interest income and other income (expense), net

13,047

8,145

38,316

23,273

Total other income (expense), net

11,707

8,145

20,376

23,273

Loss before income taxes

(74,592)

(38,292)

(259,992)

(126,219)

Income tax provision

171

764

Net loss

$              (74,763)

$              (38,292)

$            (260,756)

$             (126,219)

Net loss per share attributable to common stockholders, basic and diluted

$                  (1.05)

$                  (0.62)

$                  (3.93)

$                   (2.17)

Weighted average shares of common stock outstanding, basic and diluted

71,156,489

62,183,325

66,408,807

58,223,339

 


SELECTED BALANCE SHEET DATA


(In thousands)


(Unaudited)


December 31,


2024


2023

Cash, cash equivalents and marketable securities

$               1,118,302

$                 719,905

Working capital

$               1,078,428

$                 694,665

Total assets

$               1,141,752

$                 732,384

Total liabilities

$                    71,960

$                   31,823

Total stockholders’ equity

$               1,069,792

$                 700,561

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-outlines-pipeline-and-business-progress-reiterates-key-anticipated-milestones-and-reports-fourth-quarter-and-full-year-2024-financial-results-302386850.html

SOURCE Nuvalent, Inc.

Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend

PR Newswire


PITTSBURGH
, Feb. 27, 2025 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.

About Viatris

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedInInstagramYouTube and X (formerly Twitter).

Forward-Looking Statements
This press release includes statements that constitute “forward-looking statements.” These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements regarding Viatris’ 2025 dividend policy of 48 cents ($0.48) per share and Viatris declaring a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company’s common stock payable on March 18, 2025 to shareholders of record at the close of business on March 10, 2025. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: actions and decisions of healthcare and pharmaceutical regulators; our ability to comply with applicable laws and regulations; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris’ ability to bring new products to market; Viatris’ or its partners’ ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; Viatris’ failure to achieve expected or targeted future financial and operating performance and results; risks associated with international operations; changes in third-party relationships; the effect of any changes in Viatris’ or its partners’ customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; and the other risks described in Viatris’ filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC’s Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this press release other than as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-maintains-dividend-policy-for-2025-and-announces-quarterly-dividend-302386556.html

SOURCE Viatris Inc.

GFL Environmental Inc. Announces Commencement of Share Repurchase Program

PR Newswire


VAUGHAN, ON
, Feb. 27, 2025 /PRNewswire/ – GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today announced that the Toronto Stock Exchange (“TSX”) has accepted the Company’s notice of intention to commence a normal course issuer bid (the “NCIB”) for the 12-month period commencing on March 3, 2025 and ending no later than March 2, 2026. The NCIB will be conducted through the facilities of the TSX and the New York Stock Exchange (“NYSE”) or alternative Canadian and U.S. trading systems, if eligible.

The NCIB only relates to subordinate voting shares, of which GFL had 381,570,455 subordinate voting shares issued and outstanding as of February 18, 2025. Under the NCIB, a maximum of 28,046,256 subordinate voting shares (representing 10% of the public float (the “Public Float”) determined in accordance with TSX requirements as at February 18, 2025) may be repurchased by GFL. All subordinate voting shares repurchased by GFL under the NCIB will be cancelled.

“On January 7, 2025, we announced the sale of our Environmental Services businesses which we expect to close effective March 1, 2025,” said Patrick Dovigi, Founder and CEO of GFL.  “We have allocated up to $2.25 billion of the net proceeds from the transaction to opportunistically repurchase our subordinate voting shares. We expect to use the majority of these proceeds to purchase shares held by our sponsor shareholders, with the balance to be used for open market purchases under our normal course issuer bid.”

Purchases under the NCIB may be made by means of open market transactions, including through an automatic share purchase plan, privately negotiated transactions or such other means as a securities regulatory authority may permit. In accordance with TSX rules, any daily repurchases would be limited to a maximum of 64,492 subordinate voting shares, which represents 25% of the average daily trading volume on the TSX of 257,968 subordinate voting shares for the period from August 1, 2024 to January 31, 2025. The TSX rules also allow the Company to purchase, once a week, a block of subordinate voting shares not owned by any insiders, which may exceed such daily limit. The specific method, timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations.

Pursuant to exemptive relief granted by the Ontario Securities Commission (“OSC”) to the Company on February 26, 2025, GFL is allowed to purchase up to 10% of its Public Float through the facilities of the NYSE and other U.S.-based trading systems as part of any NCIB implemented in the 36 months following the date of the decision, and will therefore not be limited on such trading platforms to purchasing 5% of its outstanding subordinate voting shares at the beginning of any 12-month period as Canadian securities laws would otherwise provide. A copy of the decision from the OSC has been filed under GFL’s SEDAR+ profile at www.sedarplus.ca.

Subject to receiving exemptive relief from applicable securities regulatory authorities, GFL may also acquire subordinate voting shares through privately negotiated transactions. GFL expects that any private purchase made under an exemption order issued by a securities regulatory authority would be at a discount to the prevailing market price.

Under GFL’s NCIB for the 12-month period that began on May 12, 2023 and ended on May 11, 2024, GFL was authorized to repurchase up to 17,867,120 subordinate voting shares, or 5% of its then issued and outstanding subordinate voting shares. No subordinate voting shares were repurchased thereunder.

About GFL

GFL, headquartered in Vaughan, Ontario, is the fourth largest diversified environmental services company in North America, providing a comprehensive line of solid waste management, liquid waste management and soil remediation services through its platform of facilities throughout Canada and in more than half of the U.S. states. Across its organization, GFL has a workforce of more than 20,000 employees.

Cautionary Note Regarding Forward-Looking Statements 

This release includes certain “forward-looking statements”, including statements relating to the NCIB and the intended purchase for cancellation of subordinate voting shares of the Company thereunder, the methods by which any such purchases will be made, statements about the Company’s beliefs and expectations, and the timing of any of the foregoing. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management’s current beliefs, expectations, estimates and projections regarding future events and operating performance. Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by GFL as of the date of this release, are subject to inherent uncertainties, risks, changes in circumstances, and other important factors that may cause actual results to differ materially from those contemplated by the forward-looking statements, including but not limited to certain assumptions about our ability to complete the sale of the Environmental Services business on existing terms and to use the proceeds of any such sale for potential share repurchases. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the factors described in the “Risk Factors” section of GFL’s annual information form for the 2024 fiscal year filed on Form 40-F and GFL’s other periodic filings with the U.S. Securities and Exchange Commission and the securities commissions or similar regulatory authorities in Canada. These factors are not intended to represent a complete list of the factors that could affect GFL. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. GFL undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws. Purchases made under the NCIB will be subject to various factors, including GFL’s capital and liquidity positions, debt covenant restrictions, accounting and regulatory considerations, GFL’s financial and operational performance, alternative uses of capital, the trading price of GFL’s subordinate voting shares and general market conditions. The NCIB does not obligate GFL to acquire a specific dollar amount or number of shares and may be extended, modified, or discontinued at any time at the Company’s discretion.

For more information:

Patrick Dovigi
+1 905 326-0101
 [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/gfl-environmental-inc-announces-commencement-of-share-repurchase-program-302387288.html

SOURCE GFL Environmental Inc.

First Advantage Reports Fourth Quarter and Full Year 2024 Results

Completed Acquisition of Sterling; Issues Full Year 2025 Guidance

Full Year 2024 Highlights

1

  • Revenues of $860.2 million
  • Net Loss of $(110.3) million, a net loss margin of (12.8)%, includes $130.5 million of expenses incurred related to the acquisition of Sterling Check Corp. (“Sterling”)
  • Adjusted Net Income of $123.7 million
  • Adjusted EBITDA of $249.3 million; Adjusted EBITDA Margin of 29.0%
  • GAAP Diluted Net Loss Per Share of $(0.74), includes $0.66 per share of expenses incurred related to the Sterling acquisition
  • Adjusted Diluted Earnings Per Share of $0.82
  • Cash Flows from Operations of $28.2 million; Adjusted Operating Cash Flows of $164.5 million, after adjusting for $136.3 million of cash costs directly associated with the Sterling acquisition
  • Closed the Sterling acquisition on October 31, 2024, which was first announced on February 29, 2024

Fourth Quarter 2024 Highlights

1

  • Revenues of $307.1 million
  • Net Loss of $(100.4) million, a net loss margin of (32.7)%, includes $97.1 million of expenses incurred related to the acquisition of Sterling
  • Adjusted Net Income of $30.2 million
  • Adjusted EBITDA of $82.9 million; Adjusted EBITDA Margin of 27.0%
  • GAAP Diluted Net Loss Per Share of $(0.62), includes $0.43 per share of expenses incurred related to the Sterling acquisition
  • Adjusted Diluted Earnings Per Share of $0.18
  • Cash Flows from Operations of $(85.7) million; Adjusted Operating Cash Flows of $39.4 million, after adjusting for $125.1 million of cash costs directly associated with the Sterling acquisition

Full Year 2025 Guidance

  • Introducing full year 2025 guidance ranges, including the expected benefits of synergies, for Revenues of $1.5 billion to $1.6 billion, Adjusted EBITDA of $410 million to $450 million, Adjusted Net Income of $152 million to $182 million, and Adjusted Diluted Earnings Per Share of $0.86 to $1.032

ATLANTA, Feb. 27, 2025 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading global provider of employment background screening, identity, and verification solutions, today announced financial results for the fourth quarter and full year ended December 31, 2024.

Key Financials

(Amounts in millions, except per share data and percentages)

    Three Months Ended

December 31,
    Year Ended

December 31,
 
    2024     2023     2024     2023  
Revenues   $ 307.1     $ 202.6     $ 860.2     $ 763.8  
(Loss) income from operations   $ (80.7 )   $ 29.4     $ (62.4 )   $ 81.5  
Net (loss) income   $ (100.4 )   $ 14.8     $ (110.3 )   $ 37.3  
Net (loss) income margin     (32.7 )%     7.3 %     (12.8 )%     4.9 %
Diluted net (loss) income per share   $ (0.62 )   $ 0.10     $ (0.74 )   $ 0.26  
Adjusted EBITDA1   $ 82.9     $ 68.2     $ 249.3     $ 237.6  
Adjusted EBITDA Margin1     27.0 %     33.7 %     29.0 %     31.1 %
Adjusted Net Income1   $ 30.2     $ 42.6     $ 123.7     $ 145.8  
Adjusted Diluted Earnings Per Share1   $ 0.18     $ 0.29     $ 0.82     $ 1.00  

1 Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, and Adjusted Operating Cash Flow are non-GAAP measures. Please see the schedules accompanying this earnings release for a reconciliation of these measures to their most directly comparable respective GAAP measures.

“2024 was a milestone year for First Advantage as we advanced our strategy with the transformational acquisition of Sterling,” said Scott Staples, Chief Executive Officer. “We are progressing well on our integration efforts, actioning and realizing our synergy targets, and accelerating our strategic execution, all while enabling a seamless experience for customers. We have already actioned $20 million in run rate cost synergies, and we are pleased to announce that we have updated our run rate synergy target range from $50 million to $70 million previously to $60 million to $70 million. Alongside our efforts on the transaction, we have been refining our updated strategy that prioritizes growth and innovation of our business through new technologies, AI, and product initiatives.”

“For the full year and fourth quarter of 2024, we delivered solid results amid an uncertain macroeconomic environment. Considering the pre-acquisition results from Sterling, the combined company generated approximately $1.51 billion of revenues and nearly $397 million of Adjusted EBITDA in 2024. The combination of upsell, cross-sell, and new logo growth rates for the year for both First Advantage and Sterling performed in line with the respective historical revenue growth algorithms, and our team continued to demonstrate outstanding execution with important new logo and upsell bookings,” Staples concluded.

Full Year 2025 Guidance

“We are introducing our full year 2025 guidance, which includes our increased scale with the acquisition of Sterling and the expected benefits of synergies,” commented Steven Marks, Chief Financial Officer. “Our full year 2025 guidance ranges reflect the realization of synergies already actioned or expected to be actioned in 2025, our prudent posture towards growth in 2025 due in part to our expectation that base will remain a headwind through the middle of the year as we fully lap prior year base declines, and our latest view of the macroeconomic environment and labor market. In the year ahead, we plan to maintain our product and customer focus while continuing the integration process, maintaining customer continuity, actioning synergies, and reducing net leverage.”

The following table summarizes our full year 2025 guidance.

  As of February 27, 2025
Revenues $1.5 billion – $1.6 billion
Adjusted EBITDA2 $410 million – $450 million
Adjusted Net Income2 $152 million – $182 million
Adjusted Diluted Earnings Per Share2 $0.86 – $1.03

2 A reconciliation of the foregoing guidance for the non-GAAP metrics of Adjusted EBITDA and Adjusted Net Income to GAAP net (loss) income and Adjusted Diluted Earnings Per Share to GAAP diluted net (loss) income per share cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.

Actual results may differ materially from First Advantage’s full-year 2025 guidance as a result of, among other things, the factors described under “Forward-Looking Statements” below.

Conference Call and Webcast Information

First Advantage will host a conference call to review its fourth quarter and full year 2024 results today, February 27, 2025, at 8:30 a.m. ET.

To participate in the conference call, please dial 800-445-7795 (domestic) or 785-424-1699 (international) approximately ten minutes before the 8:30 a.m. ET start. Please mention to the operator that you are dialing in for the First Advantage fourth quarter and full year 2024 earnings call or provide the conference code FA4Q24. The call will also be webcast live on the Company’s investor relations website at https://investors.fadv.com under the “News & Events” and then “Events & Presentations” section, where related presentation materials will be posted prior to the conference call.

Following the conference call, a replay of the webcast will be available on the Company’s investor relations website, https://investors.fadv.com. Alternatively, the live webcast and subsequent replay will be available at https://event.on24.com/wcc/r/4818015/A54E8C5466B3E71E29525C125548AFA6.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts. These forward-looking statements relate to matters such as our industry, business strategy, goals, and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources, and other financial and operating information. In some cases, you can identify these forward-looking statements by the use of words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” “target,” “guidance,” the negative version of these words, or similar terms and phrases.

These forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Such risks and uncertainties include, but are not limited to, the following:

  • negative changes in external events beyond our control, including our customers’ onboarding volumes, economic drivers which are sensitive to macroeconomic cycles, such as interest rate volatility and inflation, geopolitical unrest, and uncertainty in financial markets;
  • our operations in a highly regulated industry and the fact that we are subject to numerous and evolving laws and regulations, including with respect to personal data, data security, and artificial intelligence;
  • inability to identify and successfully implement our growth strategies on a timely basis or at all;
  • potential harm to our business, brand, and reputation as a result of security breaches, cyber-attacks, or the mishandling of personal data;
  • our reliance on third-party data providers;
  • due to the sensitive and privacy-driven nature of our products and solutions, we could face liability and legal or regulatory proceedings, which could be costly and time-consuming to defend and may not be fully covered by insurance;
  • our international business exposes us to a number of risks;
  • the continued integration of our platforms and solutions with human resource providers such as applicant tracking systems and human capital management systems as well as our relationships with such human resource providers;
  • our ability to obtain, maintain, protect and enforce our intellectual property and other proprietary information;
  • disruptions, outages, or other errors with our technology and network infrastructure, including our data centers, servers, and third-party cloud and internet providers and our migration to the cloud;
  • our indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from meeting our obligations;
  • the failure to realize the expected benefits of our acquisition of Sterling Check Corp.; and
  • control by our Sponsor, “Silver Lake” (Silver Lake Group, L.L.C., together with its affiliates, successors, and assignees) and its interests may conflict with ours or those of our stockholders.

For additional information on these and other factors that could cause First Advantage’s actual results to differ materially from expected results, please see our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in our filings with the SEC, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is expected to be filed after this press release, which are or will be accessible on the SEC’s website at www.sec.gov. The forward-looking statements included in this press release are made only as of the date of this press release, and we undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.

Non-GAAP Financial Information

This press release contains “non-GAAP financial measures” that are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”). Specifically, we make use of the non-GAAP financial measures “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Net Income,” “Adjusted Diluted Earnings Per Share,” “Constant Currency Revenues,” “Constant Currency Adjusted EBITDA,” and “Adjusted Operating Cash Flow.”

Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Constant Currency Revenues, and Constant Currency Adjusted EBITDA have been presented in this press release as supplemental measures of financial performance that are not required by or presented in accordance with GAAP because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Constant Currency Revenues, and Constant Currency Adjusted EBITDA to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone.

Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Constant Currency Revenues, and Constant Currency Adjusted EBITDA are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) as a measure of financial performance or cash provided by (used in) operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP.

We define Adjusted EBITDA as net (loss) income before interest, taxes, depreciation, and amortization, and as further adjusted for loss on extinguishment of debt, share-based compensation, transaction and acquisition-related charges, integration and restructuring charges, and other non-cash charges. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenues. We define Adjusted Net Income for a particular period as net (loss) income before taxes adjusted for debt-related costs, acquisition-related depreciation and amortization, share-based compensation, transaction and acquisition-related charges, integration and restructuring charges, and other non-cash charges, to which we then apply the related effective tax rate. We define Adjusted Diluted Earnings Per Share as Adjusted Net Income divided by adjusted weighted average number of shares outstanding—diluted. We define Constant Currency Revenues as current period revenues translated using prior-year period exchange rates. We define Constant Currency Adjusted EBITDA as current period Adjusted EBITDA translated using prior-year period exchange rates.

Additionally, we use Adjusted Operating Cash Flow to review the liquidity of our operations. We define Adjusted Operating Cash Flow as cash flows from operating activities less cash costs directly associated with the Sterling acquisition. We believe Adjusted Operating Cash Flow is a useful supplemental financial measure for management and investors in assessing the Company’s ability to pursue business opportunities and investments and to service its debt. Adjusted Operating Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.

For reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures, see the reconciliations included at the end of this press release.

The presentations of these measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.

Numerical figures included in the reconciliations have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them.

About First Advantage

First Advantage (NASDAQ: FA) is a leading global provider of employment background screening, identity, and verification solutions. Enabled by its proprietary technology, First Advantage delivers innovative services and insights that help customers mitigate risk and hire the best talent: employees, contractors, contingent workers, tenants, and drivers. Headquartered in Atlanta, Georgia, First Advantage performs screens in over 200 countries and territories on behalf of its 80,000 customers. For more information about how to hire smarter and onboard faster with First Advantage, visit the Company’s website at https://fadv.com/.

Investor Contact

Stephanie Gorman
Vice President, Investor Relations
[email protected]
(888) 314-9761

Condensed Financial Statements

First Advantage Corporation

Condensed Consolidated Balance Sheets

(Unaudited)

    December 31,  
(in thousands, except share and per share amounts)   2024     2023  
ASSETS            
CURRENT ASSETS            
Cash and cash equivalents   $ 168,688     $ 213,774  
Restricted cash     795       138  
Accounts receivable (net of allowance for doubtful accounts of $3,832 and $1,036 at December 31, 2024 and 2023, respectively)     266,800       142,690  
Prepaid expenses and other current assets     31,041       13,426  
Income tax receivable     8,669       3,710  
Total current assets     475,993       373,738  
Property and equipment, net     307,539       79,441  
Goodwill     2,124,528       820,654  
Intangible assets, net     987,948       344,014  
Deferred tax asset, net     5,682       2,786  
Other assets     21,203       10,021  
TOTAL ASSETS   $ 3,922,893     $ 1,630,654  
LIABILITIES AND EQUITY            
CURRENT LIABILITIES            
Accounts payable   $ 120,872     $ 47,024  
Accrued compensation     52,805       16,379  
Accrued liabilities     44,700       16,162  
Current portion of long-term debt     21,850        
Current portion of operating lease liability     4,245       3,354  
Income tax payable     1,942       264  
Deferred revenues     4,274       1,856  
Total current liabilities     250,688       85,039  
Long-term debt (net of deferred financing costs of $41,861 and $6,268 at December 31, 2024 and 2023, respectively)     2,121,289       558,456  
Deferred tax liability, net     222,738       71,274  
Operating lease liability, less current portion     9,149       5,931  
Other liabilities     11,990       3,221  
Total liabilities     2,615,854       723,921  
EQUITY            
Common stock – $0.001 par value; 1,000,000,000 shares authorized, 173,171,145 and 145,074,802 shares issued and outstanding as of December 31, 2024 and 2023, respectively     173       145  
Additional paid-in-capital     1,504,007       977,290  
Accumulated deficit     (159,808 )     (49,545 )
Accumulated other comprehensive loss     (37,333 )     (21,157 )
Total equity     1,307,039       906,733  
TOTAL LIABILITIES AND EQUITY   $ 3,922,893     $ 1,630,654  



First Advantage Corporation

Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income

(Unaudited)

    Interim Periods     Annual Periods  
(in thousands, except share and per share amounts)   Three Months

Ended

December 31, 2024
    Three Months

Ended

December 31, 2023
    Year Ended

December 31, 2024
    Year Ended

December 31, 2023
 
REVENUES   $ 307,124     $ 202,562     $ 860,205     $ 763,761  
                         
OPERATING EXPENSES:                        
Cost of services (exclusive of depreciation and amortization below)     168,492       101,309       448,911       386,777  
Product and technology expense     24,765       10,889       63,817       49,263  
Selling, general, and administrative expense     138,590       27,851       263,942       116,732  
Depreciation and amortization     55,951       33,132       145,919       129,473  
Total operating expenses     387,798       173,181       922,589       682,245  
(LOSS) INCOME FROM OPERATIONS     (80,674 )     29,381       (62,384 )     81,516  
                         
OTHER EXPENSE, NET:                        
Interest expense, net     23,734       12,915       51,848       33,040  
Loss on extinguishment of debt     383             383        
Total other expense, net     24,117       12,915       52,231       33,040  
(LOSS) INCOME BEFORE PROVISION FOR INCOME TAXES     (104,791 )     16,466       (114,615 )     48,476  
(Benefit) provision for income taxes     (4,425 )     1,653       (4,342 )     11,183  
NET (LOSS) INCOME   $ (100,366 )   $ 14,813     $ (110,273 )   $ 37,293  
                         
Foreign currency translation (loss) income     (18,636 )     1,697       (16,176 )     1,174  
COMPREHENSIVE (LOSS) INCOME   $ (119,002 )   $ 16,510     $ (126,449 )   $ 38,467  
                         
NET (LOSS) INCOME   $ (100,366 )   $ 14,813     $ (110,273 )   $ 37,293  
Basic net (loss) income per share   $ (0.62 )   $ 0.10     $ (0.74 )   $ 0.26  
Diluted net (loss) income per share   $ (0.62 )   $ 0.10     $ (0.74 )   $ 0.26  
Weighted average number of shares outstanding – basic     162,774,306       143,167,422       148,582,226       144,083,808  
Weighted average number of shares outstanding – diluted     162,774,306       144,969,753       148,582,226       146,226,096  



First Advantage Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

    December 31,  
(in thousands)   2024     2023  
CASH FLOWS FROM OPERATING ACTIVITIES            
Net (loss) income   $ (110,273 )   $ 37,293  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:            
Depreciation and amortization     145,919       129,473  
Loss on extinguishment of debt     383        
Amortization of deferred financing costs     2,619       1,807  
Bad debt expense (recovery)     158       (56 )
Deferred taxes     (31,418 )     (19,497 )
Share-based compensation     31,762       15,265  
Loss on foreign currency exchange rates           8  
(Gain) loss on disposal of fixed assets and impairment of ROU assets     (275 )     1,608  
Change in fair value of interest rate swaps     (10,511 )     116  
Changes in operating assets and liabilities:            
Accounts receivable     20,775       2,339  
Prepaid expenses and other assets     (1,908 )     13,440  
Accounts payable     (25,450 )     (8,503 )
Accrued compensation and accrued liabilities     7,176       (9,301 )
Deferred revenues     762       788  
Operating lease liabilities     (883 )     (1,378 )
Other liabilities     (961 )     347  
Income taxes receivable and payable, net     321       (929 )
Net cash provided by operating activities     28,196       162,820  
CASH FLOWS FROM INVESTING ACTIVITIES            
Acquisitions of businesses, net of cash acquired     (1,619,812 )     (41,122 )
Purchases of property and equipment     (1,720 )     (2,085 )
Capitalized software development costs     (30,545 )     (25,614 )
Other investing activities     89       1,974  
Net cash used in investing activities     (1,651,988 )     (66,847 )
CASH FLOWS FROM FINANCING ACTIVITIES            
Borrowings from First Lien Credit Facility     1,679,093        
Repayments of First Lien Credit Facility     (59,200 )      
Payments of debt issuance costs     (38,212 )      
Proceeds from issuance of common stock under share-based compensation plans     14,653       4,565  
Net settlement of share-based compensation plan awards     (14,305 )     (350 )
Payments on deferred purchase agreements     (703 )     (938 )
Cash dividends paid     (255 )     (217,739 )
Share repurchases           (58,990 )
Payments on finance lease obligations     (6 )     (104 )
Net cash provided by (used in) financing activities     1,581,065       (273,556 )
Effect of exchange rate on cash, cash equivalents, and restricted cash     (1,702 )     (301 )
(Decrease) increase in cash, cash equivalents, and restricted cash     (44,429 )     (177,884 )
Cash, cash equivalents, and restricted cash at beginning of period     213,912       391,796  
Cash, cash equivalents, and restricted cash at end of period   $ 169,483     $ 213,912  
             
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:            
Cash paid for income taxes, net of refunds received   $ 23,388     $ 31,623  
Cash paid for interest   $ 65,767     $ 45,697  
NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Property and equipment acquired on account   $ 539     $ 118  
Non-cash property and equipment additions   $ 540     $  
Excise taxes on share repurchases incurred but not paid   $     $ 490  
Dividends declared but not paid   $     $ 614  



Reconciliation of Consolidated Non-GAAP Financial Measures

    Three Months Ended December 31, 2024  
(in thousands)   First Advantage

Americas
    First Advantage

International
    Sterling     Eliminations     Total revenues  
Revenues, as reported (GAAP)   $ 172,349     $ 24,020     $ 113,068     $ (2,313 )   $ 307,124  
Foreign currency translation impact (a)     126       (415 )           22       (267 )
Constant currency revenues   $ 172,475     $ 23,605     $ 113,068     $ (2,291 )   $ 306,857  

    Year Ended December 31, 2024  
(in thousands)   First Advantage

Americas
    First Advantage

International
    Sterling     Eliminations     Total revenues  
Revenues, as reported (GAAP)   $ 658,758     $ 96,854     $ 113,068     $ (8,475 )   $ 860,205  
Foreign currency translation impact (a)     165       (663 )           64       (434 )
Constant currency revenues   $ 658,923     $ 96,191     $ 113,068     $ (8,411 )   $ 859,771  

(a) Constant currency revenues is calculated by translating current period amounts using prior-year period exchange rates.

    Interim Periods     Annual Periods  
(in thousands)   Three Months

Ended

December 31, 2024
    Three Months

Ended

December 31, 2023
    Year Ended

December 31, 2024
    Year Ended

December 31, 2023
 
Net (loss) income   $ (100,366 )   $ 14,813     $ (110,273 )   $ 37,293  
Interest expense, net     23,734       12,915       51,848       33,040  
(Benefit) provision for income taxes     (4,425 )     1,653       (4,342 )     11,183  
Depreciation and amortization     55,951       33,132       145,919       129,473  
Loss on extinguishment of debt     383             383        
Share-based compensation(a)     12,459       4,816       31,762       15,265  
Transaction and acquisition-related charges(b)     93,151       532       128,234       4,364  
Integration, restructuring, and other charges(c)     2,050       373       5,771       6,938  
Adjusted EBITDA   $ 82,937     $ 68,234     $ 249,302     $ 237,556  
Revenues     307,124       202,562       860,205       763,761  
Net (loss) income margin     (32.7 )%     7.3 %     (12.8 )%     4.9 %
Adjusted EBITDA Margin     27.0 %     33.7 %     29.0 %     31.1 %
Adjusted EBITDA     82,937             249,302        
Foreign currency translation impact(d)     (11 )           59        
Constant currency Adjusted EBITDA   $ 82,926           $ 249,361        
  1. Share-based compensation for the three months ended December 31, 2024 and 2023, includes approximately $3.5 million and $2.6 million, respectively, of incrementally recognized expense associated with the May 2023 vesting modification. Share-based compensation for the years ended December 31, 2024 and 2023, include approximately $13.1 million and $6.6 million, respectively, of incrementally recognized expense associated with the May 2023 vesting modification. Share-based compensation for the three months and year ended December 31, 2024 also includes approximately $2.1 million and $4.2 million, respectively, of incrementally recognized expense associated with the retirements of the Company’s former Chief Financial Officer and former President, Americas.
  2. Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Transaction and acquisition related charges for the three months ended December 31, 2024 include approximately $92.3 million of expense associated with the acquisition of Sterling, primarily consisting of $41.2 million of compensation expense attributable to converted Sterling equity awards, of which $38.9 million related to accelerated vesting for employees terminated after the acquisition, $16.5 million in debt refinancing costs, $12.4 million of legal, regulatory, integration, and diligence professional service fees, $10.7 million in post-combination restructuring expenses, $9.5 million in success-based banking fees, and $2.0 million of other one-time transaction charges. Transaction and acquisition related charges for the year ended December 31, 2024 include approximately $125.7 million of expense associated with the acquisition of Sterling, primarily consisting of $41.2 million of compensation expense attributable to converted Sterling equity awards, of which $38.9 million related to accelerated vesting for employees terminated after the acquisition, $45.8 million of legal, regulatory, integration, and diligence professional service fees, $16.5 million in debt refinancing costs, $10.7 million in post-combination restructuring expenses, $9.5 million in success-based banking fees, and $2.0 million of other one-time transaction charges. Also includes incremental professional service fees incurred related to the initial public offering.
  3. Represents charges from organizational restructuring and integration activities, non-cash, and other charges primarily related to nonrecurring legal exposures, foreign currency (gains) losses, (gains) losses on the sale of assets, and other non-recurring items.
  4. Constant currency Adjusted EBITDA is calculated by translating current period amounts using prior-year period exchange rates.

Reconciliation of Consolidated Non-GAAP Financial Measures (continued)

    Interim Periods     Annual Periods  
(in thousands)   Three Months

Ended

December 31, 2024
    Three Months

Ended

December 31, 2023
    Year Ended

December 31, 2024
    Year Ended

December 31, 2023
 
Net (loss) income   $ (100,366 )   $ 14,813     $ (110,273 )   $ 37,293  
(Benefit) provision for income taxes     (4,425 )     1,653       (4,342 )     11,183  
(Loss) income before provision for income taxes     (104,791 )     16,466       (114,615 )     48,476  
Debt-related costs(a)     (6,232 )     5,812       549       12,845  
Acquisition-related depreciation and amortization(b)     45,079       26,044       112,966       102,659  
Share-based compensation(c)     12,459       4,816       31,762       15,265  
Transaction and acquisition-related charges(d)     93,151       532       128,234       4,364  
Integration, restructuring, and other charges(e)     2,050       373       5,771       6,938  
Adjusted Net Income before income tax effect     41,716       54,043       164,667       190,547  
Less: Adjusted income taxes(f)     11,531       11,480       40,953       44,759  
Adjusted Net Income   $ 30,185     $ 42,563     $ 123,714     $ 145,788  

    Interim Periods     Annual Periods  
    Three Months

Ended

December 31, 2024
    Three Months

Ended

December 31, 2023
    Year Ended

December 31, 2024
    Year Ended

December 31, 2023
 
Diluted net (loss) income per share (GAAP)   $ (0.62 )   $ 0.10     $ (0.74 )   $ 0.26  
Adjusted Net Income adjustments per share                        
(Benefit) provision for income taxes     (0.03 )     0.01       (0.03 )     0.08  
Debt-related costs(a)     (0.04 )     0.04       0.00       0.09  
Acquisition-related depreciation and amortization(b)     0.27       0.18       0.75       0.70  
Share-based compensation(c)     0.08       0.03       0.21       0.10  
Transaction and acquisition-related charges(d)     0.56       0.00       0.85       0.03  
Integration, restructuring, and other charges(e)     0.02       0.00       0.05       0.05  
Adjusted income taxes(f)     (0.07 )     (0.08 )     (0.27 )     (0.31 )
Adjusted Diluted Earnings Per Share

(Non-GAAP)
  $ 0.18     $ 0.29     $ 0.82     $ 1.00  
                         
Weighted average number of shares outstanding used in computation of Adjusted Diluted Earnings Per Share:  
Weighted average number of shares outstanding—diluted (GAAP)     162,774,306       144,969,753       148,582,226       146,226,096  
Options and restricted stock not included in weighted average number of shares outstanding—diluted (GAAP) (using treasury stock method)     3,178,548             2,606,405        
Adjusted weighted average number of shares outstanding—diluted (Non-GAAP)     165,952,854       144,969,753       151,188,631       146,226,096  
  1. Represents the non-cash interest expense related to the amortization of debt issuance costs for the 2021 February and 2024 October refinancing of the Company’s First Lien Credit Facility. This adjustment also includes the impact of the change in fair value of interest rate swaps, which represents the difference between the fair value gains or losses and actual cash payments and receipts on the interest rate swaps.
  2. Represents the depreciation and amortization expense related to incremental intangible and developed technology assets recorded due to the application of ASC 805, Business Combinations. As a result, the purchase accounting related depreciation and amortization expense will recur in future periods until the related assets are fully depreciated or amortized, and the related purchase accounting assets may contribute to revenue generation.
  3. Share-based compensation for the three months ended December 31, 2024 and 2023, includes approximately $3.5 million and $2.6 million, respectively, of incrementally recognized expense associated with the May 2023 vesting modification. Share-based compensation for the years ended December 31, 2024 and 2023, include approximately $13.1 million and $6.6 million, respectively, of incrementally recognized expense associated with the May 2023 vesting modification. Share-based compensation for the three months and year ended December 31, 2024 also includes approximately $2.1 million and $4.2 million, respectively, of incrementally recognized expense associated with the retirements of the Company’s former Chief Financial Officer and former President, Americas.
  4. Represents charges incurred related to acquisitions and similar transactions, primarily consisting of change in control-related costs, professional service fees, and other third-party costs. Transaction and acquisition related charges for the three months ended December 31, 2024 include approximately $92.3 million of expense associated with the acquisition of Sterling, primarily consisting of $41.2 million of compensation expense attributable to converted Sterling equity awards, of which $38.9 million related to accelerated vesting for employees terminated after the acquisition, $16.5 million in debt refinancing costs, $12.4 million of legal, regulatory, integration, and diligence professional service fees, $10.7 million in post-combination restructuring expenses, $9.5 million in success-based banking fees, and $2.0 million of other one-time transaction charges. Transaction and acquisition related charges for the year ended December 31, 2024 include approximately $125.7 million of expense associated with the acquisition of Sterling, primarily consisting of $41.2 million of compensation expense attributable to converted Sterling equity awards, of which $38.9 million related to accelerated vesting for employees terminated after the acquisition, $45.8 million of legal, regulatory, integration, and diligence professional service fees, $16.5 million in debt refinancing costs, $10.7 million in post-combination restructuring expenses, $9.5 million in success-based banking fees, and $2.0 million of other one-time transaction charges. Also includes incremental professional service fees incurred related to the initial public offering.
  5. Represents charges from organizational restructuring and integration activities, non-cash, and other charges primarily related to nonrecurring legal exposures, foreign currency (gains) losses, (gains) losses on the sale of assets, and other non-recurring items.
  6. Effective tax rates of approximately 27.6% and 21.2% have been used to compute Adjusted Net Income and Adjusted Diluted Earnings Per Share for the three months ended December 31, 2024 and 2023, respectively. Effective tax rates of approximately 24.9% and 23.5%, have been used to compute Adjusted Net Income and Adjusted Diluted Earnings Per Share for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, we had net operating loss carryforwards of approximately $15.3 million for federal income tax purposes available to reduce future income subject to income taxes. As a result, the amount of actual cash taxes we may pay for federal income taxes differs significantly from the effective income tax rate computed in accordance with GAAP and from the normalized rate shown above.
    Interim Periods     Annual Periods  
(in thousands)   Three Months

Ended

December 31, 2024
    Three Months

Ended

December 31, 2023
    Year Ended

December 31, 2024
    Year Ended

December 31, 2023
 
Cash flows from operating activities, as reported (GAAP)   $ (85,666 )   $ 56,740     $ 28,196     $ 162,820  
Cost paid related to the Sterling acquisition     125,107             136,311        
Adjusted Operating Cash Flow   $ 39,441     $ 56,740     $ 164,507     $ 162,820  



Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices

WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million, less certain adjustments as provided in the purchase agreement including certain working capital not transferring and other customary adjustments. The acquisition is subject to customary closing conditions, including receipt of certain regulatory approvals, and is expected to be completed by the end of the third quarter of 2025.

The acquisition reflects Teleflex’s commitment to investing in the estimated $10 billion interventional cardiology and peripheral vascular market served by the Company’s portfolio post close.1,2 The acquired business will expand the Teleflex Interventional portfolio to include a broad suite of vascular intervention devices such as drug-coated balloons, drug-eluting stents, covered stents, balloon and self-expanding bare metal stents, and balloon catheters. In 2023, approximately 75% of the acquired revenues were generated by coronary interventions while the remaining approximately 25% were associated with peripheral interventional procedures.3

“We are excited to announce the acquisition of BIOTRONIK’s Vascular Intervention business, which we anticipate will significantly enhance our global presence in the cath lab, expand our suite of innovative technologies, and improve patient care” said Liam Kelly, Chairman, President and Chief Executive Officer of Teleflex. “We believe the acquisition will allow us to position this advanced coronary portfolio alongside our existing Interventional business and establish our global footprint in the fast-growing peripheral intervention market. In particular, the acquired coronary products will be highly complementary to our well-established complex percutaneous coronary intervention (PCI) platform and expand and enhance the legacy Interventional salesforce and offerings by combining existing Teleflex access products with the Vascular Intervention therapeutic devices. The acquired business is rooted in robust research and development, clinical expertise, and global manufacturing capabilities, which we believe will further bolster Teleflex’s innovation pipeline, and position the company to participate in the emerging potential for resorbable scaffold technologies. We believe the acquired business will be a meaningful contributor to our growth in the coming years, diversify our geographic revenue mix with 50% of the acquired revenues generated in EMEA3, and provide additional scale for investment into innovation.”

The acquired Vascular Intervention business consists of a comprehensive and differentiated portfolio for coronary and peripheral interventions performed in the cath lab and interventional radiology suites. In coronary vascular interventions, key products include the Pantera™ Lux™ Drug-Coated Balloon Catheter, the novel PK Papyrus™ Covered Coronary Stent for acute coronary artery perforations, and the Orsiro™ Mission Drug Eluting Stent, an ultrathin drug-eluting stent with differentiated clinical features. For peripheral interventions, the portfolio includes the Passeo™-18 Lux™ Peripheral Drug-Coated Balloon Catheter, Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent, and the Pulsar™-18 T3 Self-Expanding 4F Stent.

The acquisition of the Vascular Intervention business will also allow Teleflex the opportunity to invest in and expand the clinical trial program for BIOTRONIK’s Freesolve™, a sirolimus-eluting Resorbable Metallic Scaffold (RMS) technology, including possible pursuit of the U.S. market. Freesolve™, which received its CE Mark in February 2024, is indicated in CE-mark accepting countries for de novo coronary artery lesions. The combination of temporary scaffolding with drug delivery is anticipated to address the current trend in interventional coronary and endovascular procedures toward leaving behind less permanent hardware. As demonstrated in the BIOMAG-I study, Freesolve™ RMS demonstrated resorption after 12 months, a target lesion failure rate comparable to contemporary drug-eluting stents, and no definite or probable scaffold thrombosis.4,5 The European pivotal BIOMAG-II study is now enrolling.

Teleflex’s established peer-to-peer education, patient outreach, and clinical platform for its existing Interventional business will be further leveraged by the acquired portfolio of coronary vascular and peripheral vascular intervention devices.

As the interventional cardiology and peripheral intervention markets grow on a global basis, Teleflex anticipates that this acquisition will enhance its offerings to cardiac and peripheral care specialists, while significantly advancing its corporate growth objectives.

Vascular Intervention Acquisition Financial Outlook

The acquired BIOTRONIK products delivered a constant currency revenue CAGR of 5.4% from 2022 to 2024. The acquired products are expected to generate approximately €91 million in revenues in the fourth quarter of 2025. Beginning in 2026, the BIOTRONIK acquisition is expected to deliver constant currency revenue growth of 6% or better.  

Excluding non-recurring purchase accounting items and other acquisition and integration related costs, the transaction is expected to be approximately $0.10 accretive to the Company’s adjusted earnings per share in the first year of ownership from the date of close, and to be increasingly accretive, thereafter.

Teleflex plans to initially finance the acquisition through a new term loan and revolving borrowings under its existing senior credit facility and cash on hand.

Additionally, the Company entered into foreign exchange derivative contracts to economically hedge against the foreign currency exposure associated with the cash consideration needed to complete the acquisition.

Company To Host Conference Call

The Company will host a conference call to discuss its fourth quarter financial results and provide an operational update inclusive of the transaction at 8:00 a.m. ET on Thursday, February 27, 2025. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com.

An audio replay of the call will be available beginning at 11:00 am Eastern Time on February 27, 2025, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.

About Teleflex Incorporated

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.

At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.

Not all products may be available in all countries. The above-referenced drug-coated devices are not available in the United States and Japan.

References:

  1. iData Research. (2023). Global Market Report Suite for Peripheral Vascular Devices: With Impact of COVID-19 (iDATA_GLPV24_MS).
  2. iData Research. (2023). Global Market Report Suite for Interventional Cardiology Devices: With Impact of COVID-19 (iDATA_GLIC23_MS).
  3. Based on BIOTRONIK 2023 actual net revenue at constant currency.
  4. Seguchi M, Aytekin A, Xhepa E, Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R, Garcia-Garcia HM, Joner M. Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study. EuroIntervention. 2024 Sep 16;20(18):e1173-e1183. doi: 10.4244/EIJ-D-24-00055. PMID: 39279514; PMCID: PMC11384225. The study was sponsored by BIOTRONIK. M. Seguchi, M. Haude, J.F. Iglesias, J. Bennett, G.G. Toth, M. Wiemer, G. Olivecrona, R. Waksman, H.M. Garcia-Garcia, and M. Joner are paid consultants of BIOTRONIK.
  5. Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Joner M, Toelg R, Wiemer M, Olivecrano G, Vermeersch P, Garcia-Garcia HM, Waksman R. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326. PMID: 37334655; PMCID: PMC10397670.

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements about our proposed acquisition of the Vascular Intervention business, our and the Vascular Intervention business’s commercialized and pipeline products, and the Vascular Intervention business’s technology platform, including, in each case, their potential benefits, anticipated revenue contribution, anticipated financing, anticipated accretion and the anticipated timing of completion of the proposed acquisition. Actual results could differ materially from those in the forward-looking statements due to, among other things, the possibility that the acquisition does not close; unanticipated costs and length of time required to comply with legal requirements and regulatory approvals applicable to the transaction; unanticipated difficulties and expenditures in connection with integration programs; customer and shareholder reaction to the transaction; risks associated with the financing of the transaction; disruption from the transaction making it more difficult to maintain business and operational relationships; significant transaction costs; unknown liabilities; the risk of regulatory actions related to the proposed acquisition; changes in general and international economic conditions, including fluctuations in foreign currency exchange rates; and other factors described or incorporated in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2023.

CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.

Teleflex, the Teleflex logo, Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Titan SGS, Rüsch, UroLift and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S. and/or other countries. Other names are the trademarks of their respective owners. Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings, and precautions. Information in this document is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your local representative. 

© 2025 Teleflex Incorporated. All rights reserved.

Contacts:

Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development

[email protected]


610-948-2836



Norwegian Cruise Line Holdings Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Strong demand drives 2024 revenue up ~11% to full year record

Company beats full year guidance across key metrics and announces 2025 full year guidance

MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd. (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided guidance for the first quarter and full year 2025.

Highlights

  • Generated 2024 full year record total revenue of $9.5 billion, increasing ~11% over full year 2023 on 3% capacity growth. GAAP net income was $910.3 million, up 448% compared to 2023, with EPS increasing 386%, to $1.89.
  • 2024 full year Adjusted EBITDA grew 32% to a record $2.45 billion, compared to $1.86 billion in 2023 with Adjusted EPS of $1.82.
  • Total debt was $13.1 billion and Net Leverage was 5.3x at December 31, 2024, a two turn reduction from December 31, 2023 on net cash provided by operating activities of ~$2.0 billion.
  • 2025 Adjusted EBITDA is expected to be ~$2.72 billion, or an 11.0% increase versus 2024.
  • 2025 Adjusted Net Income is expected to be ~$1.07 billion, including headwinds from foreign exchange and fuel. Adjusted EPS is expected to be ~$2.05, further establishing a clear path towards our Charting the Course 2026 targets.

“2024 was marked by strategic and transformative milestones for Norwegian Cruise Line Holdings. From launching our Charting the Course strategy, announcing an ambitious newbuild program and the construction of our Great Stirrup Cay pier, and successfully executing brand initiatives and new guest experiences across our entire portfolio, we have laid out a solid foundation for an exciting future,” said Harry Sommer, president and chief executive officer of Norwegian Cruise Line Holdings Ltd. “These achievements, driven by the dedication of our over 41,000 team members both shoreside and shipboard, led to exceptional financial performance with record revenue, Net Yield growth, and Adjusted EBITDA, enabling us to further strengthen our balance sheet and reduce our Net Leverage two full turns. Through disciplined cost management and by capitalizing on strong demand, we remain confident in achieving our 2026 Charting the Course targets.”

Full year 2024

  • Generated record total revenue of $9.5 billion, an ~11% increase compared to full year 2023 on 3% capacity growth. GAAP net income was $910.3 million, a 448% increase compared to 2023, with EPS increasing 386%, to $1.89. Performance was driven by strong revenue growth and continued execution on cost reductions and efficiencies throughout the year. In 2024, the Company recorded a $162 million or $0.31 per share benefit from a tax valuation allowance release related to US deferred tax assets and a $53 million or $0.10 per share benefit from foreign exchange.
  • Gross margin per Capacity Day was up 23% versus 2023 on an as reported and Constant Currency basis. Net Yield growth reached record levels, increasing over prior year by approximately 9.9% on an as reported and Constant Currency basis, due to strong demand and pricing across our deployment.1
  • The Company’s sustained focus on margin enhancement drove significant improvements in operating costs. Gross Cruise Costs per Capacity Day was approximately $304 for the year. Adjusted Net Cruise Cost excluding Fuel per Capacity Day was approximately $160 on an as reported and Constant Currency basis, and was up 3.9% as reported and 3.8% on a Constant Currency basis compared to $154 in 2023. Excluding a $5 impact from higher Dry-dock days and related expenses, Adjusted Net Cruise Cost excluding Fuel per Capacity day was up approximately $1, or 1%, year-over-year driven by higher variable compensation.
  • Adjusted EBITDA grew 32% to $2.45 billion, a record high, compared to $1.86 billion in 2023. Adjusted EPS grew to $1.82, which includes a $0.10 benefit from foreign exchange.
  • Total debt was $13.1 billion. Net Leverage was 5.3x at December 31, 2024, a two turn reduction from December 31, 2023.
  • Achieved Adjusted ROIC of 10.9%, a 320 basis point improvement from 7.7% in the prior year.
  • Made strong progress and on track towards achieving our Charting the Course 2026 targets announced at our May 2024 Investor Day.
  • Announced a transformative newbuild program – a total of eight state-of-the-art vessels, representing approximately 25,000 additional berths, and the construction of a multi-ship pier at Great Stirrup Cay.

1 See “Terminology”, “Non-GAAP Financial Measures” and “Outlook” below for additional information about Adjusted Net Cruise Cost excluding Fuel per Capacity Day, Adjusted EPS, Adjusted EBITDA and other non-GAAP financial measures.



Fourth Quarter 2024

  • Generated record fourth quarter total revenue of $2.1 billion, a ~6% increase compared to fourth quarter 2023 on a 1% capacity decline. GAAP net income was $254.5 million, a $361.0 million increase compared to fourth quarter 2023, with EPS increasing $0.77 to $0.52. Performance was driven by strong revenue growth and continued execution on cost efficiencies. The quarter also included a $162 million, or $0.31 per share, tax valuation allowance release related to US deferred tax assets and a $70 million, or $0.13 per share, benefit from foreign exchange rates in the quarter.2
  • Gross margin per Capacity Day was up 29% versus 2023 on an as reported and Constant Currency basis. Net Yield growth was approximately 9.0% on an as reported and Constant Currency basis, beating guidance by 210 basis points, due to strong onboard spend.
  • The Company’s focus on margin enhancement continued to drive cost savings in the quarter. Gross Cruise Costs per Capacity Day was approximately $286 for the quarter. Adjusted Net Cruise Cost excluding Fuel per Capacity Day was approximately $158 as reported and $157 on a Constant Currency basis, slightly above guidance due to increased variable compensation.
  • Adjusted EBITDA grew 30% to $468.2 million, a fourth quarter record high, compared to $359.6 million in 2023 and above guidance of approximately $445 million. Adjusted EPS exceeded guidance of $0.09, and grew to $0.26 which includes a $0.15 benefit from foreign exchange in the quarter.

2 Considering a share count of 518 million diluted weighted-average shares outstanding.



Recent Highlights

  • S&P upgraded the Company’s unsecured notes one notch to B+ with a positive outlook. Additionally, Moody’s upgraded the Company’s ratings by one notch, with the corporate rating now at B1 with a positive outlook.
  • Successfully issued $1,800 million of 6.750% Senior Unsecured Notes due 2032. The net proceeds, together with cash on hand, were used to redeem $1,200 million aggregate principal amount of the 5.875% Senior Notes due 2026 and $600 million aggregate principal amount of 8.375% Senior Secured Notes due 2028.
  • The Company successfully upsized its revolving credit facility from $1.2 billion to $1.7 billion, extending the tenor to 5-years with improved pricing.

2025 Outlook

  • 2025 full year Net Yield guidance on a Constant Currency basis is expected to increase approximately 3.0% versus 2024.
  • 2025 full year Adjusted EBITDA is expected to be approximately $2.72 billion, or an 11.0% increase versus 2024 including approximately $70 million of headwinds from foreign exchange and fuel since our third quarter earnings report.
  • Adjusted Operational EBITDA Margin for the full year 2025 is expected to increase to approximately 37%.
  • 2025 Adjusted Net Cruise Cost excluding Fuel per Capacity Day is expected to grow 1.25% on a Constant Currency basis versus 2024.
  • Full year Adjusted Net Income is expected to be approximately $1,065 million. Adjusted EPS is expected to be $2.05, increasing approximately 13% year-over-year.
  • Net Leverage is expected to end the year at approximately 5x or better.
  • Remain committed to Charting the Course targets; progressing towards achieving 2026 goals.

First Quarter 2025 Outlook

  • Net Yield is expected to increase approximately 0.5% on a Constant Currency basis versus the first quarter of 2024. This Net Yield growth comes on the back of 16.4% Net Yield growth in the first quarter of 2024 and an increase in Dry-dock capacity and repositioning days on large vessels, lowering year-over-year Occupancy.
  • First quarter 2025 Adjusted Net Cruise Cost excluding Fuel per Capacity Day is expected to grow 3.9% in Constant Currency versus 2024, which includes a 180 basis points impact of increased Dry-dock days and related costs. Excluding this, Adjusted Net Cruise Cost excluding Fuel per Capacity Day is expected to grow ~2.1%.
  • Net Leverage is expected to slightly increase to ~5.7x versus year-end 2024 as a result of the delivery of Norwegian Aqua in March.


Booking Environment Update

The Company continues to experience strong consumer demand for its offerings across itineraries and brands throughout 2025 and into 2026. As a result, the Company remains at its optimal booked position on a 12-month forward basis. Occupancy was 100.8% for the fourth quarter of 2024 and full year 2024 Occupancy was approximately 104.9%. The Company’s advance ticket sales balance, including the long-term portion, ended the fourth quarter of 2024 at $3.2 billion.


Liquidity and Financial Position

The Company is committed to prioritizing efforts to optimize its balance sheet and reduce leverage. As of December 31, 2024, the Company had total debt of $13.1 billion and Net Debt of $12.9 billion. Net Leverage improved by approximately two turns compared to December 31, 2023, ending 2024 at 5.3x.

At year-end, liquidity was $2.0 billion including approximately $190.8 million of cash and cash equivalents, $955.0 million of availability under our Revolving Loan Facility, a $650 million undrawn backstop commitment and other commitments.

“We’ve made significant strides in strengthening our financial position during 2024, reducing our Net Leverage by two full turns to 5.3 times. This progress was recently recognized by S&P’s and Moody’s, which each upgraded our credit ratings with positive outlooks,” said Mark A. Kempa, executive vice president and chief financial officer of Norwegian Cruise Line Holdings Ltd. “We’ve started 2025 strong – recently refinancing $1.8 billion of debt, which included replacing $600 million of secured debt with unsecured debt. We also upsized our revolving credit facility to $1.7 billion with improved terms. Through these strategic transactions, we have optimized our collateral utilization and strengthened our capital structure, while supporting our growth trajectory. As we progress through 2025, I am confident we will continue to improve our Net Leverage to approximately 5x or better and strengthen our balance sheet as we make strides towards our 2026 Charting the Course financial targets.”


Outlook and Guidance

In addition to announcing the results for the fourth quarter and full year 2024, the Company also provided guidance for the first quarter and full year 2025, along with accompanying sensitivities. The Company does not provide certain estimated future results on a GAAP basis because the Company is unable to predict, with reasonable certainty, the future movement of foreign exchange rates or the future impact of certain gains and charges. These items are uncertain and will depend on several factors, including industry conditions, and could be material to the Company’s results computed in accordance with GAAP. The Company has not provided reconciliations between the Company’s 2025 guidance and the most directly comparable GAAP measures because it would be too difficult to prepare a reliable U.S. GAAP quantitative reconciliation without unreasonable effort.

         
  2025 Guidance
  First Quarter 2025 Full Year 2025
  As Reported Constant
Currency
As Reported Constant
Currency
         
Net Yield ~0.1%
~$278
~0.5%
~$279
~2.4%
~$301
~3.0%
~$303
         
Adjusted Net Cruise Cost
Excluding Fuel per Capacity Day1
~3.8%
~$171
~3.9%
~$171
~0.9%
~$161
~1.25%
~$162
     
Capacity Days ~5.71 million ~24.55 million
     
Occupancy ~101.5% ~103.4%
     
Adjusted EBITDA ~$435 million ~$2.72 billion
     
Adjusted Net Income ~$37 million ~$1,065 million
     
Adjusted EPS2 ~$0.08 ~$2.05
     
Diluted Weighted-Average Shares Outstanding3 ~441 million ~520 million
     
Depreciation and Amortization ~$230 million ~$985 million
     
Adjusted Interest Expense, net4 ~$170 million ~$700 million
     
Effect of a 1% change in Net Yield on
Adjusted EBITDA / Adjusted EPS
~$16 million
~$0.04
~$74 million
~$0.14
     
Effect of a $1 change in Adjusted Net
Cruise Cost Excluding Fuel per Capacity
Day on Adjusted EBITDA / Adjusted EPS
~$6 million
~$0.01
~$25 million
~$0.05
     
Effect of a 1% change in Foreign Exchange rates
on Adjusted Net Income / Adjusted EPS
~$1.5 million
~$0.00
~$6.4 million
~$0.01

 

____________________
(1) Q1 2025 includes an approximate 180 basis point, or approximately $8 impact of increased Dry-dock days and related costs. Excluding this impact, the Adjusted Net Cruise Cost Excluding Fuel per Capacity Day would increase ~2.0% and ~2.1% on an as reported and Constant Currency basis, respectively, in the first quarter amounting to $163. We do not expect any year-over-year impact from Dry-docks in 2025.
(2) Based on guidance and using diluted weighted-average shares outstanding of approximately 441 million for the first quarter of 2025 and 520 million for full year 2025.
(3) Q1 2025 assumes all three of the Company’s exchangeable notes are anti-dilutive and therefore are not included in diluted weighted-average shares outstanding and full year 2025 assumes all three of the Company’s exchangeable notes are dilutive and therefore are included in diluted weighted-average shares outstanding.
(4) Based on the Company’s December 31, 2024 outstanding variable rate debt balance, a one percentage point increase in annual SOFR interest rates would increase the Company’s annual interest expense by approximately $8 million excluding the effects of capitalization of interest.


The following reflects the foreign currency exchange rates as of January 31, 2025 that the Company used in its first quarter and full year 2025 guidance.

       
    Current Guidance
Euro   $ 1.04
British pound   $ 1.24
Australian Dollar   $ 0.62
Canadian Dollar   $ 0.69




Fuel

The Company reported fuel expense of $160 million in the quarter. Fuel price per metric ton, net of hedges, decreased to $641 from $726 in 2023. Fuel consumption of 250,000 metric tons was in-line with projections. The following reflects the Company’s expectations regarding fuel consumption and pricing, along with accompanying sensitivities.

               
    First Quarter 2025   Full Year 2025  
Fuel consumption in metric tons1     255,000     990,000  
Fuel price per metric ton, net of hedges2   $ 690   $ 722  
Effect on Adjusted EPS of a 10% change in fuel prices, net of hedges   $ 0.01   $ 0.06  

____________________
(1) Total fuel consumption for the full year 2025 is expected to be comprised mainly of heavy fuel oil and marine gas oil, as well as other fuel types.
(2) Fuel prices are based on forward curves as of 2/11/2025.


As of December 31, 2024, the Company had hedged approximately 56% and 21% of its total projected metric tons of fuel consumption for 2025 and 2026, respectively. We primarily hedge heavy fuel oil (“HFO”) and marine gas oil (“MGO”). Other fuel types are unhedged. The following table provides amounts hedged and price per metric ton of heavy fuel oil (“HFO”) and marine gas oil (“MGO”).

               
    2025   2026  
Blended HFO and MGO Hedge Price / Metric Ton   $ 597   $ 526  
Total % of Consumption Hedged     56 %     21 %

____________________
Hedged derivatives include accounting hedges as well as economic hedges.




Capital Expenditures

The following table presents newbuild-and-growth capital expenditures, which mainly consists of capital expenditures related to the construction of new ships, private island developments and enhancements and other strategic growth initiatives:

                   
      First Quarter 2025

(millions)
  Full Year 2025

(billions)
  Full Year 2026

(billions)
  Full Year 2027

(billions)
Newbuild-and-Growth Capital Expenditures, Gross1     ~$1,295   ~$2.5   ~$2.4   ~$2.5
Export Credit Financing for Newbuild-and-Growth Capital Expenditures     ~$850   ~$1.5   ~$1.5   ~$1.8
Newbuild-and-Growth Capital Expenditures, Net of Financing     ~$445   ~$1.0   ~$1.0   ~$0.7

____________________
1. Includes all newbuild related capital expenditures including shipyard progress payments.
Note: Numbers may not add due to rounding.


The following table presents other capital expenditures, which mainly consists of investments related to maintenance, Dry-dock renovations, and technology and digital:

           
      First Quarter 2025

(millions)
  Full Year 2025

(millions)
Other Capital Expenditures     ~$130   ~$590


Company Updates and Other Business Highlights:

Company Updates

  • Appointed Jason Montague, an industry veteran with over 20 years of expertise in luxury hospitality, to Chief Luxury Officer for NCLH. In his new role, Mr. Montague will head both Regent Seven Seas Cruises and Oceania Cruises, replacing both Andrea DeMarco and Frank A. Del Rio, and oversee the execution on their multibillion-dollar fleet expansion.

Fleet and Brand Updates

  • Norwegian Cruise Line recently announced the two-time Emmy®-Award-winning actor, Eric Stonestreet, as the Company’s new brand ambassador and star of its newest advertising campaign, “Experience More.” In addition, Eric was also named the godfather of the new groundbreaking vessel, Norwegian Aqua. Learn more here.
  • Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises announced that the installation of Starlink has been completed across the entire fleet. Learn more here and here.
  • Norwegian Cruise Line unveiled all-new and expanded guest experiences aboard the Norwegian Bliss and Norwegian Breakaway. Set to undergo significant updates, the new experiences include a brand-new cinema and dining experience, Silver Screen Bistro; a new outdoor recreational concept, Horizon Park; as well as the extension of popular dining venues; and expanded accommodations including The Haven. Learn more here.


Conference Call

The Company has scheduled a conference call for Thursday, February 27, 2025 at 8:00 a.m. Eastern Time to discuss fourth quarter and full year 2024 results and provide a business update. A link to the live webcast along with a slide presentation can be found on the Company’s Investor Relations website at https://www.nclhltd.com/investors. A replay of the conference call will also be available on the website for 30 days after the call.

About Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises. With a combined fleet of 32 ships and approximately 66,500 berths, NCLH offers itineraries to approximately 700 destinations worldwide. NCLH expects to add 13 additional ships across its three brands through 2036, which will add approximately 41,000 berths to its fleet. To learn more, visit www.nclhltd.com.


Terminology

Adjusted EBITDA. EBITDA adjusted for other income (expense), net and other supplemental adjustments.

Adjusted EPS. Adjusted Net Income (Loss) divided by the number of diluted weighted-average shares outstanding.

Adjusted Gross Margin. Gross margin adjusted for payroll and related, fuel, food, other and ship depreciation. Gross margin is calculated pursuant to GAAP as total revenue less total cruise operating expense and ship depreciation.

Adjusted Net Cruise Cost Excluding Fuel. Net Cruise Cost less fuel expense adjusted for supplemental adjustments.

Adjusted Net Income (Loss). Net income (loss), adjusted for the effect of dilutive securities and other supplemental adjustments.

Adjusted Operational EBITDA Margin. Adjusted EBITDA divided by Adjusted Gross Margin.

Adjusted ROIC. An amount expressed as a percentage equal to (i) Adjusted EBITDA less depreciation and amortization plus other supplemental adjustments, divided by (ii) the sum of total long-term debt and shareholders’ equity as of the end of a respective quarter, averaged for the most recent five fiscal quarters ending with the last date of the applicable fiscal year.

Berths. Double occupancy capacity per cabin (single occupancy per studio cabin) even though many cabins can accommodate three or more passengers.

Capacity Days. Berths available for sale multiplied by the number of cruise days for the period for ships in service.

Constant Currency. A calculation whereby foreign currency-denominated revenues and expenses in a period are converted at the U.S. dollar exchange rate of a comparable period in order to eliminate the effects of foreign exchange fluctuations.

Dry-dock. A process whereby a ship is positioned in a large basin where all of the fresh/sea water is pumped out in order to carry out cleaning and repairs of those parts of a ship which are below the water line.

EBITDA. Earnings before interest, taxes, and depreciation and amortization.

EPS. Diluted earnings (loss) per share.

GAAP. Generally accepted accounting principles in the U.S.

Gross Cruise Cost. The sum of total cruise operating expense and marketing, general and administrative expense.

Net Cruise Cost. Gross Cruise Cost less commissions, transportation and other expense and onboard and other expense.

Net Cruise Cost Excluding Fuel. Net Cruise Cost less fuel expense.


Net Debt


.

Long-term debt, including current portion, less cash and cash equivalents.

Net Leverage. Net Debt divided by Adjusted EBITDA for the trailing twelve-months.

Net Per Diem. Adjusted Gross Margin divided by Passenger Cruise Days.

Net Yield. Adjusted Gross Margin per Capacity Day.

Occupancy, Occupancy Percentage or Load Factor. The ratio of Passenger Cruise Days to Capacity Days. A percentage in excess of 100% indicates that three or more passengers occupied some cabins.

Passenger Cruise Days. The number of passengers carried for the period, multiplied by the number of days in their respective cruises.

Revolving Loan Facility. $1.7 billion senior secured revolving credit facility.


Non-GAAP Financial Measures

We use certain non-GAAP financial measures, such as Adjusted Gross Margin, Adjusted Operational EBITDA Margin, Net Yield, Net Cruise Cost, Adjusted Net Cruise Cost Excluding Fuel, Adjusted EBITDA, Net Leverage, Net Debt, Adjusted Net Income (Loss), Adjusted EPS, Adjusted ROIC and Net Per Diem, to enable us to analyze our performance. See “Terminology” for the definitions of these and other non-GAAP financial measures. Our management believes the presentation of Adjusted ROIC provides a useful performance metric to both management and investors for evaluating our effective use of capital and has used it as a performance measure for our incentive compensation. We utilize Adjusted Gross Margin, Net Yield, and Net Per Diem to manage our business on a day-to-day basis because they reflect revenue earned net of certain direct variable costs. We utilize Adjusted Operational EBITDA Margin to assess operating performance. We also utilize Net Cruise Cost and Adjusted Net Cruise Cost Excluding Fuel to manage our business on a day-to-day basis. In measuring our ability to control costs in a manner that positively impacts our net income (loss), we believe changes in Adjusted Gross Margin, Adjusted Operational EBITDA Margin, Net Yield, Net Cruise Cost and Adjusted Net Cruise Cost Excluding Fuel to be the most relevant indicators of our performance.

As our business includes the sourcing of passengers and deployment of vessels outside of the U.S., a portion of our revenue and expenses are denominated in foreign currencies, particularly British pound, Canadian dollar, Euro and Australian dollar which are subject to fluctuations in currency exchange rates versus our reporting currency, the U.S. dollar. In order to monitor results excluding these fluctuations, we calculate certain non-GAAP measures on a Constant Currency basis, whereby current period revenue and expenses denominated in foreign currencies are converted to U.S. dollars using currency exchange rates of the comparable period. We believe that presenting these non-GAAP measures on both a reported and Constant Currency basis is useful in providing a more comprehensive view of trends in our business.

We believe that Adjusted EBITDA is appropriate as a supplemental financial measure as it is used by management to assess operating performance. We also believe that Adjusted EBITDA is a useful measure in determining our performance as it reflects certain operating drivers of our business, such as sales growth, operating costs, marketing, general and administrative expense and other operating income and expense. In addition, management uses Adjusted EBITDA as a performance measure for our incentive compensation. Adjusted EBITDA is not a defined term under GAAP nor is it intended to be a measure of liquidity or cash flows from operations or a measure comparable to net income (loss), as it does not take into account certain requirements such as capital expenditures and related depreciation, principal and interest payments and tax payments and it includes other supplemental adjustments.

In addition, Adjusted Net Income (Loss) and Adjusted EPS are non-GAAP financial measures that exclude certain amounts and are used to supplement GAAP net income (loss) and EPS. We use Adjusted Net Income (Loss) and Adjusted EPS as key performance measures of our earnings performance. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparison to our historical performance. In addition, management uses Adjusted EPS as a performance measure for our incentive compensation. The amounts excluded in the presentation of these non-GAAP financial measures may vary from period to period; accordingly, our presentation of Adjusted Net Income (Loss) and Adjusted EPS may not be indicative of future adjustments or results.

Net Leverage and Net Debt are performance measures that we believe provide management and investors a more complete understanding of our leverage position and borrowing capacity after factoring in cash and cash equivalents.

You are encouraged to evaluate each adjustment used in calculating our non-GAAP financial measures and the reasons we consider our non-GAAP financial measures appropriate for supplemental analysis. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur expenses similar to the adjustments in our presentation. Our non-GAAP financial measures have limitations as analytical tools, and you should not consider these measures in isolation or as a substitute for analysis of our results as reported under GAAP. Our presentation of our non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our non-GAAP financial measures may not be comparable to other companies. Please see a historical reconciliation of these measures to the most comparable GAAP measure presented in our consolidated financial statements below.


Cautionary Statement Concerning Forward-Looking Statements

Some of the statements, estimates or projections contained in this release are “forward-looking statements” within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained, or incorporated by reference, in this release, including, without limitation, our expectations regarding our results of operations, future financial position, including our liquidity requirements and future capital expenditures, plans, prospects, actions taken or strategies being considered with respect to our liquidity position, including with respect to refinancing, amending the terms of, or extending the maturity of our indebtedness, our ability to comply with covenants under our debt agreements, expectations regarding our exchangeable notes, valuation and appraisals of our assets, expectations regarding our deferred tax assets, and valuation allowances, expected fleet additions and cancellations, including expected timing thereof, our expectations regarding the impact of macroeconomic conditions and recent global events, and expectations relating to our sustainability program and decarbonization efforts may be forward-looking statements. Many, but not all, of these statements can be found by looking for words like “expect,” “anticipate,” “goal,” “project,” “plan,” “believe,” “seek,” “will,” “may,” “forecast,” “estimate,” “intend,” “future” and similar words. Forward-looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic factors, such as fluctuating or increasing levels of interest rates, inflation, unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; our indebtedness and restrictions in the agreements governing our indebtedness that require us to maintain minimum levels of liquidity and be in compliance with maintenance covenants and otherwise limit our flexibility in operating our business, including the significant portion of assets that are collateral under these agreements; our ability to work with lenders and others or otherwise pursue options to defer, renegotiate, refinance or restructure our existing debt profile, near-term debt amortization, newbuild related payments and other obligations and to work with credit card processors to satisfy current or potential future demands for collateral on cash advanced from customers relating to future cruises; our need for additional financing or financing to optimize our balance sheet, which may not be available on favorable terms, or at all, and our outstanding exchangeable notes and any future financing which may be dilutive to existing shareholders; the unavailability of ports of call; future increases in the price of, or major changes, disruptions or reduction in, commercial airline services; changes involving the tax and environmental regulatory regimes in which we operate, including new and existing regulations aimed at reducing greenhouse gas emissions; the accuracy of any appraisals of our assets; our success in controlling operating expenses and capital expenditures; adverse events impacting the security of travel, or customer perceptions of the security of travel, such as terrorist acts, armed conflict, or threats thereof, acts of piracy, and other international events; public health crises, and their effect on the ability or desire of people to travel (including on cruises); adverse incidents involving cruise ships; our ability to maintain and strengthen our brand; breaches in data security or other disturbances to our information technology systems and other networks or our actual or perceived failure to comply with requirements regarding data privacy and protection; changes in fuel prices and the type of fuel we are permitted to use and/or other cruise operating costs; mechanical malfunctions and repairs, delays in our shipbuilding program, maintenance and refurbishments and the consolidation of qualified shipyard facilities; the risks and increased costs associated with operating internationally; our inability to recruit or retain qualified personnel or the loss of key personnel or employee relations issues; impacts related to climate change and our ability to achieve our climate-related or other sustainability goals; our inability to obtain adequate insurance coverage; implementing precautions in coordination with regulators and global public health authorities to protect the health, safety and security of guests, crew and the communities we visit and to comply with related regulatory restrictions; pending or threatened litigation, investigations and enforcement actions; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; our reliance on third parties to provide hotel management services for certain ships and certain other services; fluctuations in foreign currency exchange rates; our expansion into new markets and investments in new markets and land-based destination projects; overcapacity in key markets or globally; and other factors set forth under “Risk Factors” in our most recently filed Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. The above examples are not exhaustive and new risks emerge from time to time. There may be additional risks that we currently consider immaterial or which are unknown. Such forward-looking statements are based on our current beliefs, assumptions, expectations, estimates and projections regarding our present and future business strategies and the environment in which we expect to operate in the future. You are cautioned not to place undue reliance on the forward-looking statements included in this release, which speak only as of the date made. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based, except as required by law.


Investor Relations & Media Contacts

Sarah Inmon
(786) 812-3233
[email protected]

 
NORWEGIAN CRUISE LINE HOLDINGS LTD.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except share and per share data)
 
    Three Months Ended   Year Ended
    December 31,    December 31, 
    2024     2023     2024     2023  
Revenue                        
Passenger ticket   $ 1,408,734     $ 1,333,057     $ 6,415,545     $ 5,753,966  
Onboard and other     700,632       653,399       3,064,106       2,795,958  
Total revenue     2,109,366       1,986,456       9,479,651       8,549,924  
Cruise operating expense                        
Commissions, transportation and other     415,580       420,714       1,917,443       1,883,279  
Onboard and other     146,057       129,633       661,553       599,904  
Payroll and related     332,429       325,882       1,344,718       1,262,119  
Fuel     160,418       186,830       698,050       716,833  
Food     73,142       86,735       312,992       358,310  
Other     179,953       172,019       753,940       648,142  
Total cruise operating expense     1,307,579       1,321,813       5,688,696       5,468,587  
Other operating expense                        
Marketing, general and administrative     360,566       328,258       1,434,807       1,341,858  
Depreciation and amortization     226,480       212,055       890,242       808,568  
Total other operating expense     587,046       540,313       2,325,049       2,150,426  
Operating income     214,741       124,330       1,465,906       930,911  
Non-operating income (expense)                        
Interest expense, net     (175,358 )     (197,381 )     (747,223 )     (727,531 )
Other income (expense), net     68,337       (35,266 )     54,224       (40,204 )
Total non-operating income (expense)     (107,021 )     (232,647 )     (692,999 )     (767,735 )
Net income (loss) before income taxes     107,720       (108,317 )     772,907       163,176  
Income tax benefit     146,816       1,832       137,350       3,002  
Net income (loss)   $ 254,536     $ (106,485 )   $ 910,257     $ 166,178  
Weighted-average shares outstanding                        
Basic     439,709,089       425,426,293       435,278,605       424,424,962  
Diluted     518,111,963       425,426,293       515,030,548       427,400,849  
Earnings (loss) per share                        
Basic   $ 0.58     $ (0.25 )   $ 2.09     $ 0.39  
Diluted   $ 0.52     $ (0.25 )   $ 1.89     $ 0.39  

 
NORWEGIAN CRUISE LINE HOLDINGS LTD.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(in thousands)
 
    Three Months Ended   Year Ended
    December 31,    December 31, 
    2024     2023     2024     2023  
Net income (loss)   $ 254,536     $ (106,485 )   $ 910,257     $ 166,178  
Other comprehensive income (loss):                        
Shipboard Retirement Plan     6,835       (3,604 )     7,118       (3,413 )
Cash flow hedges:                        
Net unrealized loss     (2,974 )     (36,606 )     (10,642 )     (1,773 )
Amount realized and reclassified into earnings     8,776       (12,283 )     4,923       (26,173 )
Total other comprehensive income (loss)     12,637       (52,493 )     1,399       (31,359 )
Total comprehensive income (loss)   $ 267,173     $ (158,978 )   $ 911,656     $ 134,819  

 
NORWEGIAN CRUISE LINE HOLDINGS LTD.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands, except share data)
 
       December 31,       December 31, 
    2024     2023  
Assets            
Current assets:            
Cash and cash equivalents   $ 190,765     $ 402,415  
Accounts receivable, net     221,412       280,271  
Inventories     149,718       157,646  
Prepaid expenses and other assets     448,209       472,816  
Total current assets     1,010,104       1,313,148  
Property and equipment, net     16,810,650       16,433,292  
Goodwill     135,764       98,134  
Trade names     500,525       500,525  
Other long-term assets     1,512,768       1,147,891  
Total assets   $ 19,969,811     $ 19,492,990  
Liabilities and shareholders’ equity            
Current liabilities:            
Current portion of long-term debt   $ 1,323,769     $ 1,744,778  
Accounts payable     171,106       174,338  
Accrued expenses and other liabilities     1,180,026       1,058,919  
Advance ticket sales     3,105,964       3,060,666  
Total current liabilities     5,780,865       6,038,701  
Long-term debt     11,776,721       12,314,147  
Other long-term liabilities     986,786       839,335  
Total liabilities     18,544,372       19,192,183  
Commitments and contingencies            
Shareholders’ equity:            
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; and 439,861,281 shares issued and outstanding at December 31, 2024 and 425,546,570 shares issued and outstanding at December 31, 2023     440       425  
Additional paid-in capital     7,921,918       7,708,957  
Accumulated other comprehensive income (loss)     (507,039 )     (508,438 )
Accumulated deficit     (5,989,880 )     (6,900,137 )
Total shareholders’ equity     1,425,439       300,807  
Total liabilities and shareholders’ equity   $ 19,969,811     $ 19,492,990  

 
NORWEGIAN CRUISE LINE HOLDINGS LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(in thousands)
 
    Year Ended
    December 31, 
    2024     2023  
Cash flows from operating activities            
Net income   $ 910,257     $ 166,178  
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization expense     973,512       883,236  
Deferred income taxes, net     (155,114 )      
(Gain) loss on derivatives     (979 )     13,760  
Loss on extinguishment of debt     29,175       6,701  
Provision for bad debts and inventory obsolescence     6,359       6,190  
Gain on involuntary conversion of assets     (4,771 )     (6,852 )
Share-based compensation expense     91,781       118,940  
Net foreign currency adjustments on euro-denominated debt     (25,837 )     8,188  
Changes in operating assets and liabilities:            
Accounts receivable, net     49,304       39,649  
Inventories     6,950       (11,042 )
Prepaid expenses and other assets     88,366       410,266  
Accounts payable     (20,208 )     (50,976 )
Accrued expenses and other liabilities     65,348       (82,202 )
Advance ticket sales     35,680       503,678  
Net cash provided by operating activities     2,049,823       2,005,714  
Cash flows from investing activities            
Additions to property and equipment, net     (1,210,952 )     (2,750,362 )
Cash paid on settlement of derivatives     (1,789 )     (162,942 )
Acquisition, net of cash acquired     (27,322 )      
Other     10,675       16,161  
Net cash used in investing activities     (1,229,388 )     (2,897,143 )
Cash flows from financing activities            
Repayments of long-term debt     (2,169,045 )     (3,758,234 )
Proceeds from long-term debt     1,298,599       4,322,941  
Proceeds from employee related plans           5,307  
Net share settlement of restricted share units     (25,333 )     (26,860 )
Early redemption premium     (19,166 )      
Deferred financing fees     (117,140 )     (196,297 )
Net cash provided by (used in) financing activities     (1,032,085 )     346,857  
Net decrease in cash and cash equivalents     (211,650 )     (544,572 )
Cash and cash equivalents at beginning of the period     402,415       946,987  
Cash and cash equivalents at end of the period   $ 190,765     $ 402,415  



NORWEGIAN CRUISE LINE HOLDINGS LTD.


NON-GAAP RECONCILING INFORMATION

(Unaudited)

The following table sets forth selected statistical information:

 
    Three Months Ended   Year Ended  
    December 31,    December 31,   
    2024   2023   2024   2023  
Passengers carried   665,788   648,893   2,926,794   2,716,546  
Passenger Cruise Days   5,881,777   5,856,413   24,593,331   23,311,672  
Capacity Days   5,834,290   5,903,305   23,445,397   22,652,588  
Occupancy Percentage   100.8 % 99.2 % 104.9 % 102.9 %


Adjusted Gross Margin, Net Per Diem, and Net Yield were calculated as follows (in thousands, except Net Yield, Net Per Diem, Capacity Days, Passenger Cruise Days, per Passenger Cruise Day and Capacity Day data):

    Three Months Ended   Year Ended
    December 31,    December 31, 
        2024           2024    
        Constant Currency           Constant Currency    
    2024   compared to 2023   2023   2024   compared to 2023   2023
Total revenue   $ 2,109,366   $ 2,108,996   $ 1,986,456   $ 9,479,651   $ 9,481,599   $ 8,549,924
Less:                                    
Total cruise operating expense     1,307,579     1,306,522     1,321,813     5,688,696     5,686,128     5,468,587
Ship depreciation     208,054     208,054     198,012     825,493     825,493     753,629
Gross margin     593,733     594,420     466,631     2,965,462     2,969,978     2,327,708
Ship depreciation     208,054     208,054     198,012     825,493     825,493     753,629
Payroll and related     332,429     332,397     325,882     1,344,718     1,344,620     1,262,119
Fuel     160,418     160,387     186,830     698,050     697,993     716,833
Food     73,142     72,700     86,735     312,992     312,625     358,310
Other     179,953     179,078     172,019     753,940     751,350     648,142
Adjusted Gross Margin   $ 1,547,729   $ 1,547,036   $ 1,436,109   $ 6,900,655   $ 6,902,059   $ 6,066,741
                                     
Passenger Cruise Days     5,881,777     5,881,777     5,856,413     24,593,331     24,593,331     23,311,672
Capacity Days     5,834,290     5,834,290     5,903,305     23,445,397     23,445,397     22,652,588
                                     
Total revenue per Passenger Cruise Day   $ 358.63   $ 358.56   $ 339.19   $ 385.46   $ 385.54   $ 366.77
Gross margin per Passenger Cruise Day   $ 100.94   $ 101.06   $ 79.68   $ 120.58   $ 120.76   $ 99.85
Net Per Diem   $ 263.14   $ 263.02   $ 245.22   $ 280.59   $ 280.65   $ 260.24
                                     
Gross margin per Capacity Day   $ 101.77   $ 101.88   $ 79.05   $ 126.48   $ 126.68   $ 102.76
Net Yield   $ 265.28   $ 265.16   $ 243.27   $ 294.33   $ 294.39   $ 267.82



NORWEGIAN CRUISE LINE HOLDINGS LTD.


NON-GAAP RECONCILING INFORMATION

(Unaudited)

Gross Cruise Cost, Net Cruise Cost, Net Cruise Cost Excluding Fuel and Adjusted Net Cruise Cost Excluding Fuel were calculated as follows (in thousands, except Capacity Days and per Capacity Day data):

    Three Months Ended   Year Ended
    December 31,    December 31, 
        2024           2024    
        Constant Currency           Constant Currency    
    2024   compared to 2023   2023   2024   compared to 2023   2023
Total cruise operating expense   $ 1,307,579   $ 1,306,522   $ 1,321,813   $ 5,688,696   $ 5,686,128   $ 5,468,587
Marketing, general and administrative expense     360,566     360,668     328,258     1,434,807     1,434,245     1,341,858
Gross Cruise Cost     1,668,145     1,667,190     1,650,071     7,123,503     7,120,373     6,810,445
Less:                                    
Commissions, transportation and other expense     415,580     415,903     420,714     1,917,443     1,917,987     1,883,279
Onboard and other expense     146,057     146,057     129,633     661,553     661,553     599,904
Net Cruise Cost     1,106,508     1,105,230     1,099,724     4,544,507     4,540,833     4,327,262
Less: Fuel expense     160,418     160,387     186,830     698,050     697,993     716,833
Net Cruise Cost Excluding Fuel     946,090     944,843     912,894     3,846,457     3,842,840     3,610,429
Less Other Non-GAAP Adjustments:                                    
Non-cash deferred compensation (1)     719     719     578     2,875     2,875     2,312
Non-cash share-based compensation (2)     26,211     26,211     22,686     91,781     91,781     118,940
Adjusted Net Cruise Cost Excluding Fuel   $ 919,160   $ 917,913   $ 889,630   $ 3,751,801   $ 3,748,184   $ 3,489,177
                                     
Capacity Days     5,834,290     5,834,290     5,903,305     23,445,397     23,445,397     22,652,588
                                     
Gross Cruise Cost per Capacity Day   $ 285.92   $ 285.76   $ 279.52   $ 303.83   $ 303.70   $ 300.65
Net Cruise Cost per Capacity Day   $ 189.66   $ 189.44   $ 186.29   $ 193.83   $ 193.68   $ 191.03
Net Cruise Cost Excluding Fuel per Capacity Day   $ 162.16   $ 161.95   $ 154.64   $ 164.06   $ 163.91   $ 159.38
Adjusted Net Cruise Cost Excluding Fuel per Capacity Day   $ 157.54   $ 157.33   $ 150.70   $ 160.02   $ 159.87   $ 154.03

____________________
(1) Non-cash deferred compensation expenses related to the crew pension plan and other crew expenses, which are included in payroll and related expense.
(2) Non-cash share-based compensation expenses related to equity awards, which are included in marketing, general and administrative expense and payroll and related expense.



NORWEGIAN CRUISE LINE HOLDINGS LTD.

NON-GAAP RECONCILING INFORMATION

(Unaudited)

Adjusted Net Income and Adjusted EPS were calculated as follows (in thousands, except share and per share data):

    Three Months Ended   Year Ended
    December 31,    December 31, 
    2024     2023     2024     2023
Net income (loss)   $ 254,536     $ (106,485 )   $ 910,257     $ 166,178
Effect of dilutive securities – exchangeable notes     14,985             63,308      
Net income (loss) and assumed conversion of exchangeable notes     269,521       (106,485 )     973,565       166,178
Non-GAAP Adjustments:                        
Non-cash deferred compensation (1)     1,233       1,010       4,930       4,039
Non-cash share-based compensation (2)     26,211       22,686       91,781       118,940
Extinguishment and modification of debt (3)           5,669       29,175       8,822
Reversal of U.S. deferred tax asset valuation allowance (4)     (161,926 )           (161,926 )    
Effect of dilutive securities – exchangeable notes (5)     (10,310 )                
Adjusted Net Income (Loss)   $ 124,729     $ (77,120 )   $ 937,525     $ 297,979
                         
Diluted weighted-average shares outstanding – Net income (loss)     518,111,963       425,426,293       515,030,548       427,400,849
Diluted weighted-average shares outstanding – Adjusted Net Income (Loss) (5)     480,401,556       425,426,293       515,030,548       427,400,849
                         
Diluted EPS   $ 0.52     $ (0.25 )   $ 1.89     $ 0.39
Adjusted EPS   $ 0.26     $ (0.18 )   $ 1.82     $ 0.70

____________________
(1) Non-cash deferred compensation expenses related to the crew pension plan and other crew expenses, which are included in payroll and related expense and other income (expense), net.
(2) Non-cash share-based compensation expenses related to equity awards, which are included in marketing, general and administrative expense and payroll and related expense.
(3) Losses on extinguishment of debt and modification of debt are included in interest expense, net.
(4) Non-cash income tax benefit related to the reversal of a valuation allowance on our U.S. deferred tax assets. The deferred tax assets accumulated during the COVID-19 pandemic and a portion of the valuation allowance was released related to the deferred tax assets that more likely than not will be realized in the future. We consider this adjustment to be nonrecurring as it originated as a result of losses incurred during the pandemic and future income tax expense is not expected to change materially as a result of the reversal.
(5) The impact of the above add-backs results in an anti-dilutive effect on Adjusted EPS related to our exchangeable notes for which we are reducing the impact on GAAP net income and dilutive weighted average shares. 


EBITDA and Adjusted EBITDA were calculated as follows (in thousands):

    Three Months Ended   Year Ended
    December 31,    December 31, 
    2024     2023     2024     2023  
Net income (loss)   $ 254,536     $ (106,485 )   $ 910,257     $ 166,178  
Interest expense, net     175,358       197,381       747,223       727,531  
Income tax benefit     (146,816 )     (1,832 )     (137,350 )     (3,002 )
Depreciation and amortization expense     226,480       212,055       890,242       808,568  
EBITDA     509,558       301,119       2,410,372       1,699,275  
Other (income) expense, net (1)     (68,337 )     35,266       (54,224 )     40,204  
Other Non-GAAP Adjustments:                        
Non-cash deferred compensation (2)     719       578       2,875       2,312  
Non-cash share-based compensation (3)     26,211       22,686       91,781       118,940  
Adjusted EBITDA   $ 468,151     $ 359,649     $ 2,450,804     $ 1,860,731  

 

____________________
(1) Primarily consists of gains and losses, net for foreign currency remeasurements.
(2) Non-cash deferred compensation expenses related to the crew pension plan and other crew expenses, which are included in payroll and related expense.
(3) Non-cash share-based compensation expenses related to equity awards, which are included in marketing, general and administrative expense and payroll and related expense.


Net Debt and Net Leverage were calculated as follows (in thousands):

    December 31,    December 31, 
    2024   2023
Long-term debt   $ 11,776,721   $ 12,314,147
Current portion of long-term debt     1,323,769     1,744,778
Total Debt     13,100,490     14,058,925
Less: Cash and cash equivalents     190,765     402,415
Net Debt   $ 12,909,725   $ 13,656,510
             
Adjusted EBITDA for the twelve months ended   $ 2,450,804   $ 1,860,731
             
Net Leverage     5.27x     7.34x



NORWEGIAN CRUISE LINE HOLDINGS LTD.


NON-GAAP RECONCILING INFORMATION

(Unaudited)

Adjusted ROIC was calculated as follows (in thousands):

             
    December 31,    December 31, 
    2024     2023  
Adjusted EBITDA   $ 2,450,804     $ 1,860,731  
Less: Depreciation and Amortization     890,242       808,568  
Total     1,560,562       1,052,163  
Plus: Total long-term debt plus shareholders equity     14,333,899       13,705,994  
Adjusted Return on Invested Capital     10.9%       7.7%  


Our capital expenditures were previously presented classified as new-build related and non-newbuild. The presentation of capital expenditures under this classification is as follows (in millions):

      Fourth Quarter 2024   Full Year 2024
Newbuild-Related Capital Expenditures, Pre-Financing     $79   $619
Export Credit Financing for Newbuild-Related Capital Expenditures     $43   $355
Newbuild-Related Capital Expenditures, Net of Financing     $36   $264

           
      Fourth Quarter 2024   Full Year 2024
Non-Newbuild Capital Expenditures     $149   $583



Civeo Reports Fourth Quarter and Full Year 2024 Results

Civeo Reports Fourth Quarter and Full Year 2024 Results

Highlights:

  • Reported fourth quarter 2024 revenues of $151.0 million, net loss of $15.1 million and operating cash flow of $9.5 million, with full year 2024 revenues of $682.1 million, net loss of $17.1 million and operating cash flow of $83.5 million;

  • Reported fourth quarter 2024 Adjusted EBITDA of $11.4 million with full year 2024 Adjusted EBITDA of $79.9 million;

  • Returned $44.0 million of capital to shareholders in 2024 through the quarterly dividend and share repurchases, representing 65% of 2024 free cash flow of $68.4 million;

  • Recently announced a six-year A$1.4 billion Australian integrated services contract renewal with expanded scope, showing strength of Civeo’s long-term relationships;

  • Australian revenues in the fourth quarter grew by 23% year-over-year, led by the recently announced integrated services contract renewal; and

  • Subsequent to quarter end, executed on disciplined growth strategy by entering into an agreement to acquire four villages and associated long-term contracts in the Australian Bowen Basin. Upon closing, the transaction is expected to be immediately accretive to cash flow. See press release dated February 19, 2025.

HOUSTON & CALGARY, Alberta–(BUSINESS WIRE)–
Civeo Corporation (NYSE:CVEO) today reported financial and operating results for the fourth quarter and year ended December 31, 2024.

Bradley J. Dodson, Civeo’s President and Chief Executive Officer said, “2024 marked our 10-year anniversary as an independent company since our spin-off in 2014, and over that time our business has undergone significant change. Today, having significantly improved our capital structure, we are a diversified company providing catering and facility management services at both owned and customer-owned assets. This balanced portfolio lets us capitalize on tailwinds and mitigate headwinds. For the full-year 2024, we returned 65% of our free cash flow to shareholders through our quarterly dividend and share repurchases.”

“I’m pleased with the fourth quarter results of our Australia business, delivering 23% year-over-year revenue growth, supported by the execution of our integrated services growth strategy including a recently announced six-year, A$1.4 billion contract. We are leveraging our core competency of taking care of people into a larger, capital-light market opportunity in Australia. Since entering this market via acquisition in 2019, we have successfully delivered a five-year topline organic compound annual growth rate of 38% with minimal capital investment.”

“In addition, our Australian owned villages continue to experience strong occupancy levels driven by steady operational mining activity. To further capitalize on the Bowen Basin market dynamics, we recently announced an agreement to acquire four additional villages in the basin. Consistent with our strategy in our existing villages, the villages to be acquired are largely contracted under two-to-three-year contracts with new and existing blue-chip customers. This acquisition is expected to be immediately accretive to operating cash flow and will expand our presence in the world’s premier metallurgical coal basin.”

“Our Canadian business continued to face headwinds in the oil sands region, compounded by economic and political uncertainty. For the past decade, the underlying economics for our oil sands customers to deploy capital in the region have been challenging. Now, in addition, our customers are facing increased investor pressure for capital and operating cost discipline. As a result, headcount requirements, and therefore our occupancy in the Alberta oil sands region have declined. To address this new reality, we are right sizing our Canadian cost structure and looking to expand our geographic and end market reach to reduce our dependence on oil sands activity. During the first quarter of 2025, we expect to incur one-time restructuring costs of approximately $3 million as we cold-close existing lodges and reduce overhead headcount by approximately 25%.”

Mr. Dodson continued, “To better illustrate the evolution of our business and our current asset mix, we have provided supplemental data in our earnings release tables that discloses the revenue of the ‘asset light’ portion of our business, which includes hospitality services at both our owned and customer-owned assets, and the ‘asset intensive’ portion of our business, which largely includes accommodation revenue associated with our owned-lodge and village assets as well as our Canadian mobile camp business.”

Mr. Dodson concluded, “We enter 2025 with confidence in our ability to continue to execute on our growth strategy while adhering to our capital allocation framework.”

Fourth Quarter 2024 Results

In the fourth quarter of 2024, Civeo reported revenues of $151.0 million and reported a net loss of $15.1 million, or $1.10 per diluted share. During the fourth quarter of 2024, Civeo produced operating cash flow of $9.5 million, Adjusted EBITDA of $11.4 million and free cash flow of $2.1 million.

By comparison, in the fourth quarter of 2023, Civeo generated revenues of $170.8 million and reported net income of $23.0 million, or $1.55 per diluted share. During the fourth quarter of 2023, Civeo produced operating cash flow of $40.0 million, Adjusted EBITDA of $18.5 million and free cash flow of $39.2 million.

The decrease in Adjusted EBITDA in the fourth quarter of 2024 compared to 2023 was primarily due to decreased billed rooms at the Canadian lodges. This lower level of customer spending is expected to continue as producers in the region remain focused on reducing operating costs. The year-over-year decrease in free cash flow was negatively impacted by net proceeds related to the sale of McClelland Lake Lodge and holdback collections related to the wind down of Canadian mobile camp projects in the fourth quarter of 2023.

Full Year 2024 Results

For the full year 2024, the Company reported revenues of $682.1 million and net loss of $17.1 million, or $1.19 per diluted share. Adjusted EBITDA for the full year 2024 was $79.9 million. This is compared to revenues of $700.8 million and net income of $30.2 million, or $2.01 per diluted share, for the full year 2023. Adjusted EBITDA was $106.5 million in 2023.

The decrease in Adjusted EBITDA in 2024 as compared to 2023 was largely driven by the sale of McClelland Lake Lodge in 2023 and the expected wind-down of LNG related activity in Canada, partially offset by increased billed rooms in the Australian owned villages and increased Australian integrated services activity.

Business Segment Results

(Unless otherwise noted, the following discussion compares the quarterly results for the fourth quarter of 2024 to the results for the fourth quarter of 2023.)

Australia

During the fourth quarter of 2024, the Australia segment generated revenues of $110.0 million, operating income of $14.1 million and Adjusted EBITDA of $22.2 million, compared to revenues of $89.3 million, operating income of $14.9 million and Adjusted EBITDA of $21.5 million in the fourth quarter of 2023.

The Australian segment experienced a 23% increase in revenues and a 3% increase in Adjusted EBITDA, driven by a significant increase in integrated services activity related to the recently announced contract.

On January 9, 2025, the Company announced a six-year A$1.4 billion integrated services contract renewal with an expanded scope in Australia. Civeo began performing the incremental scope of this contract under a limited notice to proceed agreement in the second quarter of 2024, and this contract became effective starting January 1, 2025.

Canada

During the fourth quarter of 2024, the Canada segment generated revenues of $40.7 million, operating loss of $16.8 million and negative Adjusted EBITDA of $4.7 million, compared to revenues of $72.7 million, operating income of $16.1 million and Adjusted EBITDA of $3.5 million in the fourth quarter of 2023.

The Canadian segment experienced a 44% decrease in revenues driven by lower billed rooms, down 42% year-over-year, primarily due to the sale of the McClelland Lake lodge and lower occupancy at the Sitka Lodge. This decrease was exacerbated by higher than typical turnaround activity in the fourth quarter of 2023.

As stated above, Civeo is taking several strategic actions to mitigate current macroeconomic risks. During the first quarter of 2025, Civeo will incur one-time restructuring costs of approximately $3 million.

Financial Condition and Capital Allocation

As of December 31, 2024, Civeo had total liquidity of approximately $202.2 million. Civeo’s total debt on December 31, 2024 was $43.3 million, a $6.8 decrease from September 30, 2024 and a $22.3 million decrease from December 31, 2023. Civeo’s net debt on December 31, 2024 was $38.1 million, a $5.9 million increase from September 30, 2024 and a $24.1 million decrease from December 31, 2023.

For the full year 2024, the Company repurchased 1,130,000 shares for approximately $29.6 million, compared to 564,000 shares for $11.6 million in 2023.

Civeo reported a net leverage ratio of 0.5x as of December 31, 2024.

For the full year 2024, Civeo invested $26.1 million in capital expenditures, down from $31.6 million during 2023. Capital expenditures in both periods were primarily related to planned maintenance spending on the Company’s lodges and villages. Capital expenditures in 2023 included approximately $10.0 million related to customer-funded infrastructure upgrades at three Australian villages which were reimbursed by Civeo’s customer compared to $2.9 million in 2024.

The Company previously announced that its Board of Directors declared a quarterly cash dividend of $0.25 per common share, payable on March 17, 2025 to shareholders of record as of close of business on February 24, 2025. For purposes of the Income Tax Act (Canada), the Company has designated this dividend to be an “eligible dividend”.

In the fourth quarter of 2024, Civeo repurchased approximately 208,000 shares through its share repurchase program for approximately $5.6 million.

Full Year 2025 Guidance

For the full year of 2025, excluding any contribution from the recently announced Australian asset acquisition, Civeo expects revenues of $630.0 million to $660.0 million, Adjusted EBITDA of $80.0 million to $90.0 million and capital expenditures of $25.0 million to $30.0 million. This guidance takes into account the recent reduction in currency exchange rates experienced since late 2024.

The Company expects the recently announced Australian asset acquisition to be completed by the end of the second quarter of 2025, subject to regulatory approvals and customary conditions, and we will provide updated 2025 guidance upon completion.

Supplemental Data Disclosure:

In addition to the Company’s standard earnings release schedules, please see below additional supplemental data schedule disclosing results associated with the asset-light (integrated services) portion of our business and the asset-intensive (accommodation) portion of our business within each of its two reporting segments.

Conference Call

Civeo will host a conference call to discuss its fourth quarter 2024 financial results today at 11:00 a.m. Eastern time. This call is being webcast and can be accessed at Civeo’s website at www.civeo.com. Participants may also join the conference call by dialing (877) 423-9813 in the United States or (201) 689-8573 internationally and asking for the Civeo call or using the conference ID 13751856#. A replay will be available after the call by dialing (844) 512-2921 in the United States or (412) 317-6671 internationally and using the conference ID 13751856#.

About Civeo

Civeo Corporation is a leading provider of hospitality services with prominent market positions in the Australian natural resource and the Canadian oil sands regions. Civeo offers comprehensive solutions for lodging hundreds or thousands of workers with its long-term and temporary accommodations and provides food services, housekeeping, facility management, laundry, water and wastewater treatment, power generation, communications systems, security and logistics services. Civeo currently owns and operates a total of 24 lodges and villages in Australia and North America with an aggregate of approximately 26,000 rooms. In addition, Civeo operates and provides hospitality services at 22 customer-owned locations with more than 18,000 rooms. Civeo is publicly traded under the symbol CVEO on the New York Stock Exchange. For more information, please visit Civeo’s website at www.civeo.com

Forward Looking Statements

This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those that do not state historical facts and are, therefore, inherently subject to risks and uncertainties. The forward-looking statements herein, including the statements regarding Civeo’s future plans and outlook, strategic priorities, guidance, current trends,expectations with respect to Adjusted EBITDA, capital expenditures, share repurchases and dividends, liquidity needs, and the proposed Australian asset acquisition, including its associated benefits and anticipated closing date, are based on then current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Such risks and uncertainties include, among other things, risks associated with the general nature of the accommodations industry, risks associated with the level of supply and demand for oil, coal, iron ore and other minerals, including the level of activity, spending and developments in the Canadian oil sands, the level of demand for coal and other natural resources from, and investments and opportunities in, Australia, and fluctuations or sharp declines in the current and future prices of oil, natural gas, coal, iron ore and other minerals, risks associated with failure by our customers to reach positive final investment decisions on, or otherwise not complete, projects with respect to which we have been awarded contracts, which may cause those customers to terminate or postpone contracts, risks associated with currency exchange rates, risks associated with inflation and volatility in the banking sector, risks associated with the company’s ability to integrate any acquisitions, risks associated with labor shortages, risks associated with the development of new projects, including whether such projects will continue in the future, risks associated with the trading price of the company’s common shares, availability and cost of capital, risks associated with general global economic conditions, geopolitical events, inflation, global weather conditions, natural disasters, global health concerns, and security threats and changes to government and environmental regulations, including climate change, and other factors discussed in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Civeo’s most recent annual report on Form 10-K and other reports the company may file from time to time with the U.S. Securities and Exchange Commission. Each forward-looking statement contained herein speaks only as of the date of this release. Except as required by law, Civeo expressly disclaims any intention or obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Non-GAAP Financial Information

EBITDA, Adjusted EBITDA, free cash flow, net debt, bank-adjusted EBITDA and net leverage ratio are non-GAAP financial measures. See “Non-GAAP Reconciliation” below for definitions and additional information concerning non-GAAP financial measures, including a reconciliation of the non-GAAP financial information presented in this press release to the most directly comparable financial information presented in accordance with GAAP. Non-GAAP financial information supplements and should be read together with, and is not an alternative or substitute for, the Company’s financial results reported in accordance with GAAP. Because non-GAAP financial information is not standardized, it may not be possible to compare these financial measures with other companies’ non-GAAP financial measures.

– Financial Schedules Follow –

 

CIVEO CORPORATION

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

 

 

 

Revenues

 

$

150,951

 

 

$

170,799

 

 

$

682,122

 

 

$

700,805

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

Cost of sales and services

 

 

122,846

 

 

 

135,052

 

 

 

532,667

 

 

 

530,287

 

Selling, general and administrative expenses

 

 

17,642

 

 

 

19,720

 

 

 

73,350

 

 

 

72,605

 

Depreciation and amortization expense

 

 

16,769

 

 

 

15,865

 

 

 

68,038

 

 

 

75,142

 

Impairment expense

 

 

3,758

 

 

 

1,395

 

 

 

11,581

 

 

 

1,395

 

(Gain) loss on sale of McClelland Lake Lodge assets, net

 

 

73

 

 

 

(23,458

)

 

 

(5,744

)

 

 

(18,590

)

Other operating expense (income)

 

 

(94

)

 

 

177

 

 

 

898

 

 

 

479

 

 

 

 

160,994

 

 

 

148,751

 

 

 

680,790

 

 

 

661,318

 

Operating income (loss)

 

 

(10,043

)

 

 

22,048

 

 

 

1,332

 

 

 

39,487

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(1,685

)

 

 

(2,552

)

 

 

(7,973

)

 

 

(13,177

)

Interest income

 

 

40

 

 

 

46

 

 

 

187

 

 

 

172

 

Other income (expense)

 

 

(450

)

 

 

10,845

 

 

 

517

 

 

 

13,881

 

Income (loss) before income taxes

 

 

(12,138

)

 

 

30,387

 

 

 

(5,937

)

 

 

40,363

 

Income tax expense

 

 

(3,293

)

 

 

(7,736

)

 

 

(12,492

)

 

 

(10,633

)

Net income (loss)

 

 

(15,431

)

 

 

22,651

 

 

 

(18,429

)

 

 

29,730

 

Less: Net loss attributable to noncontrolling interest

 

 

(361

)

 

 

(374

)

 

 

(1,362

)

 

 

(427

)

Net income (loss) attributable to Civeo Corporation

 

$

(15,070

)

 

$

23,025

 

 

$

(17,067

)

 

$

30,157

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to Civeo Corporation common shareholders:

 

 

 

 

 

 

 

 

Basic

 

$

(1.10

)

 

$

1.57

 

 

$

(1.19

)

 

$

2.02

 

Diluted

 

$

(1.10

)

 

$

1.55

 

 

$

(1.19

)

 

$

2.01

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

13,688

 

 

 

14,687

 

 

 

14,287

 

 

 

14,906

 

Diluted

 

 

13,688

 

 

 

14,855

 

 

 

14,287

 

 

 

15,013

 

CIVEO CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

 

December 31, 2024

 

December 31, 2023

 

 

(UNAUDITED)

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

5,204

 

 

$

3,323

 

Accounts receivable, net

 

 

89,038

 

 

 

143,222

 

Inventories

 

 

7,537

 

 

 

6,982

 

Assets held for sale

 

 

 

 

 

5,873

 

Prepaid expenses and other current assets

 

 

8,674

 

 

 

15,846

 

Total current assets

 

 

110,453

 

 

 

175,246

 

 

 

 

 

 

Property, plant and equipment, net

 

 

204,897

 

 

 

270,563

 

Goodwill, net

 

 

7,001

 

 

 

7,690

 

Other intangible assets, net

 

 

66,502

 

 

 

77,999

 

Operating lease right-of-use assets

 

 

9,401

 

 

 

12,286

 

Other noncurrent assets

 

 

6,818

 

 

 

4,278

 

Total assets

 

$

405,072

 

 

$

548,062

 

 

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

39,971

 

 

$

58,699

 

Accrued liabilities

 

 

34,933

 

 

 

40,523

 

Income taxes

 

 

10,853

 

 

 

3,831

 

Deferred revenue

 

 

2,501

 

 

 

4,849

 

Other current liabilities

 

 

4,388

 

 

 

6,334

 

Total current liabilities

 

 

92,646

 

 

 

114,236

 

 

 

 

 

 

Long-term debt

 

 

43,299

 

 

 

65,554

 

Deferred income taxes

 

 

3,558

 

 

 

11,803

 

Operating lease liabilities

 

 

6,655

 

 

 

9,264

 

Other noncurrent liabilities

 

 

21,916

 

 

 

24,167

 

Total liabilities

 

 

168,074

 

 

 

225,024

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

Common shares

 

 

 

 

 

 

Additional paid-in capital

 

 

1,631,823

 

 

 

1,628,972

 

Accumulated deficit

 

 

(980,720

)

 

 

(919,023

)

Treasury stock

 

 

(10,130

)

 

 

(9,063

)

Accumulated other comprehensive loss

 

 

(404,600

)

 

 

(380,715

)

Total Civeo Corporation shareholders’ equity

 

 

236,373

 

 

 

320,171

 

Noncontrolling interest

 

 

625

 

 

 

2,867

 

Total shareholders’ equity

 

 

236,998

 

 

 

323,038

 

Total liabilities and shareholders’ equity

 

$

405,072

 

 

$

548,062

 

 

CIVEO CORPORATION

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

Net income (loss)

 

$

(18,429

)

 

$

29,730

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

68,038

 

 

 

75,142

 

Impairment charges

 

 

11,581

 

 

 

1,395

 

Deferred income tax expense (benefit)

 

 

(7,659

)

 

 

6,806

 

Non-cash compensation charge

 

 

2,851

 

 

 

4,460

 

Gain on disposals of assets

 

 

(6,418

)

 

 

(21,196

)

Provision for loss on receivables, net of recoveries

 

 

26

 

 

 

135

 

Other, net

 

 

1,742

 

 

 

1,660

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable

 

 

44,228

 

 

 

(22,311

)

Inventories

 

 

(1,224

)

 

 

5

 

Accounts payable and accrued liabilities

 

 

(17,581

)

 

 

7,438

 

Taxes payable

 

 

7,878

 

 

 

3,576

 

Other current assets and liabilities, net

 

 

(1,523

)

 

 

9,725

 

Net cash flows provided by operating activities

 

 

83,510

 

 

 

96,565

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

Capital expenditures

 

 

(26,138

)

 

 

(31,633

)

Proceeds from disposition of property, plant and equipment

 

 

11,011

 

 

 

16,740

 

Other, net

 

 

183

 

 

 

372

 

Net cash flows used in investing activities

 

 

(14,944

)

 

 

(14,521

)

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

Term loan repayments

 

 

 

 

 

(29,899

)

Revolving credit borrowings (repayments), net

 

 

(17,117

)

 

 

(37,846

)

Dividends paid

 

 

(14,422

)

 

 

(7,423

)

Debt issuance costs

 

 

(2,976

)

 

 

 

Repurchases of common shares

 

 

(29,616

)

 

 

(11,634

)

Other, net

 

 

(1,067

)

 

 

 

Net cash flows used in financing activities

 

 

(65,198

)

 

 

(86,802

)

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(1,487

)

 

 

127

 

Net change in cash and cash equivalents

 

 

1,881

 

 

 

(4,631

)

 

 

 

 

 

Cash and cash equivalents, beginning of period

 

 

3,323

 

 

 

7,954

 

Cash and cash equivalents, end of period

 

$

5,204

 

 

$

3,323

 

CIVEO CORPORATION

SEGMENT DATA

(in thousands)

(unaudited)

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Revenues

 

 

 

 

 

 

 

 

Canada

 

$

40,664

 

 

$

72,728

 

 

$

245,087

 

 

$

352,795

 

Australia

 

 

109,989

 

 

 

89,345

 

 

 

426,956

 

 

 

336,763

 

Other

 

 

298

 

 

 

8,726

 

 

 

10,079

 

 

 

11,247

 

Total revenues

 

$

150,951

 

 

$

170,799

 

 

$

682,122

 

 

$

700,805

 

 

 

 

 

 

 

 

 

 

EBITDA (1)

 

 

 

 

 

 

 

 

Canada

 

$

(8,146

)

 

$

36,519

 

 

$

23,798

 

 

$

86,502

 

Australia

 

 

22,128

 

 

 

21,469

 

 

 

80,622

 

 

 

74,069

 

Corporate, other and eliminations

 

 

(7,345

)

 

 

(8,856

)

 

 

(33,171

)

 

 

(31,634

)

Total EBITDA

 

$

6,637

 

 

$

49,132

 

 

$

71,249

 

 

$

128,937

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA (1)

 

 

 

 

 

 

 

 

Canada

 

$

(4,711

)

 

$

3,507

 

 

$

21,743

 

 

$

58,827

 

Australia

 

 

22,205

 

 

 

21,540

 

 

 

86,622

 

 

 

74,357

 

Corporate, other and eliminations

 

 

(6,054

)

 

 

(6,523

)

 

 

(28,428

)

 

 

(26,690

)

Total adjusted EBITDA

 

$

11,440

 

 

$

18,524

 

 

$

79,937

 

 

$

106,494

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

 

Canada

 

$

(16,809

)

 

$

16,050

 

 

$

(14,727

)

 

$

27,977

 

Australia

 

 

14,062

 

 

 

14,870

 

 

 

49,524

 

 

 

44,982

 

Corporate, other and eliminations

 

 

(7,296

)

 

 

(8,872

)

 

 

(33,465

)

 

 

(33,472

)

Total operating income (loss)

 

$

(10,043

)

 

$

22,048

 

 

$

1,332

 

 

$

39,487

 

 

 

 

 

 

 

 

(1) Please see Non-GAAP Reconciliation Schedule.

 

 

 

 

 

 

 

CIVEO CORPORATION

SUPPLEMENTAL QUARTERLY SEGMENT AND OPERATING DATA

(U.S. dollars in thousands, except for room counts and average daily rates)

(unaudited)

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

Supplemental Operating Data – Australian Segment

 

 

 

 

 

 

 

 

Accommodation and other services revenue (1)

 

$

49,293

 

$

46,881

 

$

196,684

 

$

177,834

Food and other services revenue (3)

 

 

60,696

 

 

42,464

 

 

230,272

 

 

158,929

Total Australian revenues

 

$

109,989

 

$

89,345

 

$

426,956

 

$

336,763

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

Accommodation and other services cost

 

$

23,354

 

$

21,791

 

$

94,344

 

$

85,461

Food and other services cost

 

 

54,409

 

 

38,467

 

 

208,627

 

 

148,599

Indirect other cost

 

 

3,394

 

 

2,305

 

 

12,403

 

 

8,951

Total Australian cost of sales and services

 

$

81,157

 

$

62,563

 

$

315,374

 

$

243,011

 

 

 

 

 

 

 

 

 

Average daily rates (4)

 

$

77

 

$

74

 

$

78

 

$

75

 

 

 

 

 

 

 

 

 

Billed rooms (5)

 

 

637,461

 

 

637,759

 

 

2,524,108

 

 

2,371,763

 

 

 

 

 

 

 

 

 

Australian dollar to U.S. dollar

 

$

0.652

 

$

0.651

 

$

0.660

 

$

0.665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental Operating Data – Canadian Segment

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Accommodation and other services revenue (1)

 

$

33,981

 

$

58,926

 

$

214,774

 

$

266,926

Mobile facility rental revenue (2)

 

 

50

 

 

7,147

 

 

1,523

 

 

61,899

Food and other services revenue (3)

 

 

6,633

 

 

6,655

 

 

28,790

 

 

23,970

Total Canadian revenues

 

$

40,664

 

$

72,728

 

$

245,087

 

$

352,795

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

Accommodation and other services cost

 

$

31,410

 

$

45,251

 

$

164,089

 

$

195,843

Mobile facility rental cost

 

 

527

 

 

11,337

 

 

4,940

 

 

49,073

Food and other services cost

 

 

6,362

 

 

6,120

 

 

27,201

 

 

21,821

Indirect other cost

 

 

2,678

 

 

2,637

 

 

10,905

 

 

10,330

Total Canadian cost of sales and services

 

$

40,977

 

$

65,345

 

$

207,135

 

$

277,067

 

 

 

 

 

 

 

 

 

Average daily rates (4)

 

$

94

 

$

95

 

$

97

 

$

97

 

 

 

 

 

 

 

 

 

Billed rooms (5)

 

 

359,537

 

 

617,325

 

 

2,205,700

 

 

2,710,784

 

 

 

 

 

 

 

 

 

Canadian dollar to U.S. dollar

 

$

0.715

 

$

0.734

 

$

0.730

 

$

0.741

 

(1) Includes revenues related to lodge and village rooms and hospitality services for owned rooms for the periods presented.

(2) Includes revenues related to mobile camps for the periods presented.

(3) Includes revenues related to food service, laundry and water and wastewater treatment services, and facilities management for the periods presented.

(4) Average daily rate is based on billed rooms and accommodation and other services revenue.

(5) Billed rooms represents total billed days for Civeo owned Canadian lodges and Australian villages for the periods presented.

CIVEO CORPORATION

SUPPLEMENTAL OPERATIONS BY SERVICE TYPE BY REGION DATA

(U.S. dollars in thousands)

(unaudited)

The following table sets forth certain supplemental data for our Australia and Canada segment revenues attributable to the asset-light (“Catering and Facility Management”) portion of the Company’s business and the asset-intensive (“Accommodations and Infrastructure”) portion of the Company’s business. We provide Catering and Facility Management services to both customer-owned assets and Company-owned villages and lodges. When we provide Catering and Facility Management services to customer-owned assets, it is reflected in “Food and other services” in our Supplemental Quarterly Segment and Operating Data. However, when we provide those same services to customers at our owned villages and lodges, it is reflected in “Accommodation and other services”, which also includes the Accommodations and Infrastructure component of our owned villages and lodges. This is because we bill our customers in one combined rate for both Accommodations and Infrastructure services and Catering and Facility Management services at Company-owned villages and lodges.

The purpose of the disclosure below is to disaggregate the embedded Catering and Facility Management revenues from the “Accommodation and other services” revenues associated with our owned villages and lodges that is included in our Supplemental Quarterly Segment and Operating Data. To do so, we apply a margin that is equal to Civeo’s margin in similar services we provide to customer-owned assets to the cost of sales that are associated with Catering and Facility Management services within “Accommodation and other services” for our owned villages and lodges. This table provides investors a supplemental view of the services provided by the Company which could assist with their valuation analysis.

 

 

Twelve Months Ended

December 31, 2024

 

Twelve Months Ended

December 31, 2023

 

 

Australia

 

Canada

 

Other

 

Total

 

Australia

 

Canada

 

Other

 

Total

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset Light: Catering and Facility management

 

$

312,993

 

$

146,469

 

$

2,407

 

$

461,869

 

$

232,730

 

$

162,589

 

$

3,044

 

$

398,363

Asset Intensive: Accommodations and Infrastructure

 

 

113,963

 

 

98,618

 

 

7,672

 

 

220,253

 

 

104,033

 

 

190,206

 

 

8,203

 

 

302,442

Total revenues

 

$

426,956

 

$

245,087

 

$

10,079

 

$

682,122

 

$

336,763

 

$

352,795

 

$

11,247

 

$

700,805

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CIVEO CORPORATION

NON-GAAP RECONCILIATIONS

(in thousands)

(unaudited)

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

EBITDA (1)

 

$

6,637

 

$

49,132

 

$

71,249

 

$

128,937

Adjusted EBITDA (1)

 

$

11,440

 

$

18,524

 

$

79,937

 

$

106,494

Free Cash Flow (2)

 

$

2,074

 

$

39,188

 

$

68,383

 

$

81,672

Net Leverage Ratio (3)

 

 

 

 

 

0.5x

 

 

(1)

 

The term EBITDA is a non-GAAP financial measure that is defined as net income (loss) attributable to Civeo Corporation plus interest, taxes, depreciation and amortization. The term Adjusted EBITDA is a non-GAAP financial measure that is defined as EBITDA adjusted to exclude certain other unusual or non-operating items. EBITDA and Adjusted EBITDA are not measures of financial performance under generally accepted accounting principles and should not be considered in isolation from or as a substitute for net income or cash flow measures prepared in accordance with generally accepted accounting principles or as a measure of profitability or liquidity. Additionally, EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures of other companies. Civeo has included EBITDA and Adjusted EBITDA as supplemental disclosures because its management believes that EBITDA and Adjusted EBITDA provide useful information regarding its ability to service debt and to fund capital expenditures and provide investors a helpful measure for comparing Civeo’s operating performance with the performance of other companies that have different financing and capital structures or tax rates. Civeo uses EBITDA and Adjusted EBITDA to compare and to monitor the performance of its business segments to other comparable public companies and as a benchmark for the award of incentive compensation under Civeo’s annual incentive compensation plan.

 

 

The following table sets forth a reconciliation of EBITDA and Adjusted EBITDA to net income (loss) attributable to Civeo Corporation, which is the most directly comparable measure of financial performance calculated under generally accepted accounting principles (in thousands) (unaudited):

 

 

 

 

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Civeo Corporation

 

$

(15,070

)

 

$

23,025

 

 

$

(17,067

)

 

$

30,157

 

Income tax provision (benefit)

 

 

3,293

 

 

 

7,736

 

 

 

12,492

 

 

 

10,633

 

Depreciation and amortization

 

 

16,769

 

 

 

15,865

 

 

 

68,038

 

 

 

75,142

 

Interest income

 

 

(40

)

 

 

(46

)

 

 

(187

)

 

 

(172

)

Interest expense

 

 

1,685

 

 

 

2,552

 

 

 

7,973

 

 

 

13,177

 

EBITDA

 

$

6,637

 

 

$

49,132

 

 

$

71,249

 

 

$

128,937

 

Adjustments to EBITDA

 

 

 

 

 

 

 

 

Impairment of long-lived assets (a)

 

 

3,758

 

 

 

1,395

 

 

 

11,581

 

 

 

1,395

 

Net (gain) loss on disposition of McClelland Lake Lodge assets (b)

 

 

73

 

 

 

(33,166

)

 

 

(5,744

)

 

 

(28,298

)

Share-based compensation (c)

 

 

972

 

 

 

1,163

 

 

 

2,851

 

 

 

4,460

 

Adjusted EBITDA

 

$

11,440

 

 

$

18,524

 

 

$

79,937

 

 

$

106,494

 

(a)

 

Relates to asset impairments in the first and fourth quarters of 2024 and the fourth quarter of 2023. In the fourth quarter of 2024, we recorded a pre-tax loss related to the impairment of long-lived assets in our Canadian segment of $3.2 million and a pre-tax loss related to the impairment of long-lived assets in the U.S. of $0.5 million. In the first quarter of 2024, we recorded a pre-tax loss related to the impairment of long-lived assets in our Australian segment of $5.7 million and a pre-tax loss related to the impairment of long-lived assets in the U.S. of $2.1 million. In the fourth quarter of 2023, we recorded a pre-tax loss related to the impairment of long-lived assets in the U.S. of $1.4 million.

(b)

 

Relates to proceeds received and expenses incurred associated with the dismantlement and sale of the McClelland Lake Lodge. In the fourth, third and second quarters of 2024, we recorded expenses associated with the sale of our McClelland Lake Lodge of $0.1 million, $0.2 million and $0.1 million, respectively, which are included in (Gain) loss on sale of McClelland Lake Lodge assets, net on the unaudited statements of operations. In the first quarter of 2024, we recorded gains associated with the sale of the McClelland Lake Lodge of $6.1 million, which are included in (Gain) loss on sale of McClelland Lake Lodge assets, net on the unaudited statements of operations. In the fourth quarter of 2023, we recorded gains associated with the sale of the McClelland Lake Lodge of $33.2 million, which are included in (Gain) loss on sale of McClelland Lake Lodge assets, net ($23.5 million) and Other income ($9.7 million) on the unaudited statements of operations. In the third quarter of 2023, we recorded expenses associated with the sale of our McClelland Lake Lodge of $4.9 million, which are included in (Gain) loss on sale of McClelland Lake Lodge assets, net on the unaudited statements of operations.

(c)

 

Represents share-based compensation expense associated with performance share awards, restricted share awards, restricted share units and deferred share awards.

(2)

 

The term Free Cash Flow is a non-GAAP financial measure that is defined as net cash flows provided by operating activities less capital expenditures plus proceeds from asset sales. Free Cash Flow is not a measure of financial performance under generally accepted accounting principles and should not be considered in isolation from or as a substitute for cash flow measures prepared in accordance with generally accepted accounting principles or as a measure of profitability or liquidity. Additionally, Free Cash Flow may not be comparable to other similarly titled measures of other companies. Civeo has included Free Cash Flow as a supplemental disclosure because its management believes that Free Cash Flow provides useful information regarding the cash flow generating ability of its business relative to its capital expenditure and debt service obligations. Civeo uses Free Cash Flow to compare and to understand, manage, make operating decisions and evaluate Civeo’s business. It is also used as a benchmark for the award of incentive compensation under its annual incentive compensation plan.

 

 

The following table sets forth a reconciliation of Free Cash Flow to Net Cash Flows Provided by Operating Activities, which is the most directly comparable measure of financial performance calculated under generally accepted accounting principles (in thousands) (unaudited):

 

 

 

Three Months Ended

December 31,

 

Twelve Months Ended

December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

 

 

 

 

Net Cash Flows Provided by Operating Activities

 

$

9,496

 

 

$

39,972

 

 

$

83,510

 

 

$

96,565

 

Capital expenditures

 

 

(7,733

)

 

 

(10,454

)

 

 

(26,138

)

 

 

(31,633

)

Proceeds from disposition of property, plant and equipment

 

 

311

 

 

 

9,670

 

 

 

11,011

 

 

 

16,740

 

Free Cash Flow

 

$

2,074

 

 

$

39,188

 

 

$

68,383

 

 

$

81,672

 

(3)

 

The term net leverage ratio is a non-GAAP financial measure that is defined as net debt divided by bank-adjusted EBITDA.

Net debt, bank-adjusted EBITDA and net leverage ratio are not financial measures under GAAP and should not be considered in isolation from or as a substitute for total debt, net income (loss) or cash flow measures prepared in accordance with GAAP or as a measure of profitability or liquidity. Additionally, net debt, bank-adjusted EBITDA and net leverage ratio may not be comparable to other similarly titled measures of other companies. Civeo has included net debt, bank-adjusted EBITDA and net leverage ratio as a supplemental disclosure because its management believes that this data provides useful information regarding the level of the Company’s indebtedness and its ability to service debt. Additionally, per Civeo’s credit agreement, the Company is required to maintain a net leverage ratio below 3.0x every quarter to remain in compliance with the credit agreement.

 

 

 

 

The following table sets forth a reconciliation of net debt, bank-adjusted EBITDA and net leverage ratio to the most directly comparable measures of financial performance calculated under GAAP (in thousands) (unaudited):

 

 

 

As of December 31,

 

 

 

2024

 

 

 

Total debt

 

$

43,299

Less: Cash and cash equivalents

 

 

5,204

Net debt

 

$

38,095

 

 

 

Adjusted EBITDA for the twelve months ended December 31, 2024 (a)

 

$

79,937

Adjustments to Adjusted EBITDA

 

 

Interest income

 

 

187

Incremental adjustments for McClelland Lake Lodge disposition (b)

 

 

332

Bank-adjusted EBITDA

 

$

80,456

 

 

 

Net leverage ratio (c)

 

0.5x

 

 

(a)See footnote 1 above for reconciliation of Adjusted EBITDA to net income (loss) attributable to Civeo Corporation.

(b) Related to incremental adjustments associated with the sale of the McClelland Lake Lodge assets as required by our credit facility.

(c) Calculated as net debt divided by bank-adjusted EBITDA.

CIVEO CORPORATION

NON-GAAP RECONCILIATIONS – GUIDANCE

(in millions)

(unaudited)

 

 

 

 

 

Year Ending

December 31, 2025

EBITDA Range (1)

 

$

74.3

 

$

84.3

Adjusted EBITDA Range (1)

 

$

80.0

 

$

90.0

(1)

 

The following table sets forth a reconciliation of estimated EBITDA and Adjusted EBITDA to estimated net loss, which is the most directly comparable measure of financial performance calculated under generally accepted accounting principles (in millions) (unaudited):

 

 

Year Ending

December 31, 2025

 

 

(estimated)

 

 

 

 

 

Net loss

 

$

(11.7

)

 

$

(3.7

)

Income tax provision

 

 

14.0

 

 

 

16.0

 

Depreciation and amortization

 

 

67.0

 

 

 

67.0

 

Interest expense

 

 

5.0

 

 

 

5.0

 

EBITDA

 

$

74.3

 

 

$

84.3

 

Adjustments to EBITDA

 

 

 

 

Canadian restructuring cost

 

 

2.9

 

 

 

2.9

 

Share-based compensation

 

 

2.8

 

 

 

2.8

 

Adjusted EBITDA

 

$

80.0

 

 

$

90.0

 

 

Regan Nielsen

Civeo Corporation

Vice President, Corporate Development & Investor Relations

713-510-2400

KEYWORDS: North America United States Australia Australia/Oceania Canada Texas

INDUSTRY KEYWORDS: Construction & Property Other Energy Oil/Gas Energy Mining/Minerals Lodging Other Construction & Property Natural Resources Residential Building & Real Estate Travel

MEDIA:

Logo
Logo

NCR Voyix Strengthens Payments Offering through Processing Agreement with Worldpay

NCR Voyix Strengthens Payments Offering through Processing Agreement with Worldpay

ATLANTA–(BUSINESS WIRE)–
NCR Voyix Corporation (NYSE: VYX), a leading global provider of digital commerce solutions, today announced it has entered into an agreement with Worldpay®, a global industry leader in payments technology, to enable NCR Voyix to offer a combined cloud-based software and payments solution to retailers and restaurants. NCR Voyix will leverage Worldpay’s industry-leading acquiring services to provide NCR Voyix customers with an integrated payments acceptance offering.

“This relationship brings together the global scale of Worldpay’s acquiring capabilities and NCR Voyix, strengthening our payments offerings and enabling the delivery of more comprehensive solutions to our retail and restaurant customers,” said Darren Wilson, President, Retail & Payments, NCR Voyix. “Integrating Worldpay’s world class payment processing capabilities into NCR Voyix’s platform will broaden our valued customer relationships, allowing us to serve as the single point-of-contact for all point-of-sale and payment needs.”

“NCR Voyix is a trusted technology provider for the world’s leading retailers and restaurants. Worldpay brings its global reach and deep vertical product set to this relationship,” said Matt Downs, Group President, Worldpay for Platforms. “Worldpay for Platforms’ industry leading solutions are designed to serve a wide range of vertical software companies. The combination of these solutions and Worldpay’s leading global e-commerce capabilities will allow NCR Voyix to provide an exceptional omnichannel payment processing product for its customer base.”

About NCR Voyix

NCR Voyix Corporation (NYSE: VYX) is a leading global provider of digital commerce solutions for the retail and restaurant industries. NCR Voyix transforms retail stores and restaurant systems through experiences with comprehensive, platform-led SaaS and services capabilities. NCR Voyix is headquartered in Atlanta, Georgia, with customers in more than 30 countries across the globe.

About Worldpay

Worldpay is an industry leading payments technology and solutions company with unique capabilities to power omni-commerce across the globe. Our processing solutions allow businesses of all sizes to take, make and manage payments in-person and online from anywhere in the world. Annually, we process over 50 billion transactions across 146 countries and 135 currencies. We help our customers become more efficient, more secure and more successful. To learn more, visit worldpay.com or follow us on LinkedIn, Instagram, X, and or Facebook.

Cautionary Statements

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 (the “Act”). We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Act. There are a number of important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including the risks and uncertainties described in the “Risk Factors” section of NCR Voyix’s Annual Report on Form 10-K, as well as in its other reports filed with the U.S. Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. NCR Voyix does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

News Media Contact

Kymberly Graham

[email protected]

Investor Contact

Sarah Jane Schneider

[email protected]

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Technology Payments Other Retail Fintech Electronic Commerce Professional Services Software Restaurant/Bar Retail

MEDIA:

Logo
Logo